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Abstract 
Inflammatory bowel disease (IBD) is a group of diseases that affect the gastrointestinal 
tract.  Environmental factors, such as smoking, have been shown to play a role in the 
development of IBD; however, minimal research regarding secondhand smoke (SHS) 
exposure and the development of IBD has been conducted.  The purpose of this study 
was to examine whether there was a relationship between childhood SHS exposure and 
the development of IBD.  Bronfenbrenner’s ecological systems theory was used in this 
study as a basis that the environment can aid in the development of disease.  The research 
questions addressed the potential association between childhood SHS exposure and IBD 
development as well as the association between childhood SHS exposure and the age at 
diagnosis.  A quantitative, cross-sectional design was used to analyze secondary data 
collected by a government organization regarding childhood SHS exposure and IBD 
status as well as other demographic, genetic, and environmental factors.  There were 74 
participants who met the inclusion factors to be included in this study.  Multinomial 
logistic regression was conducted to analyze the variables in the data.  The results 
indicated no significant relationship between childhood SHS exposure and IBD 
development as well as no significant relationship between childhood SHS exposure and 
the age of diagnosis.  The results of this research can be used to inform future studies 
regarding the association of SHS exposure and IBD and possibly increase knowledge 
regarding individual risk factors for IBD and how physicians diagnose and treat patients. 
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Chapter 1: Introduction to the Study 
Introduction 
Inflammatory bowel disease (IBD) is a group of autoimmune, inflammatory, 
digestive diseases that consist of ulcerative colitis (UC) and Crohn’s disease (CD) 
(Crohn’s and Colitis Foundation [CCF], 2014; Moran, 2017).  UC can result in 
inflammation of the colon, while CD can result in inflammation throughout the entire 
digestive tract (CCF, 2014; Moran, 2017).  The age of diagnosis for the development of 
UC and CD is between 15 and 35 years old, although disease diagnosis can occur at any 
age for either disease (CCF, 2014; Moran, 2017).  The exact causes of UC and CD are 
not entirely known (CCF, 2014; Moran, 2017).  Hereditary, genetic, and environmental 
factors can facilitate the development of CD, while genetics, the immune system, and the 
environment can play a part in the development of UC (CCF, 2014; Moran, 2017).  These 
two types of IBD are common in families and affect males and females equally but affect 
Whites (including Jews of European descent) more than other ethnicities (CCF, 2014, 
2019b; Moran, 2017).  However, CD has been shown to have a higher chance of running 
in families than UC, especially if a first-degree relative has IBD (CCF, 2019a).  
Examination of environmental factors has shown that IBD occurs more in developed 
countries, urban areas, and northern climates when compared to undeveloped countries, 
rural areas, and southern climates (CCF, 2014).  IBD might be associated with foreign 
substances in the environment that might trigger the immune response but not inactivate 
the immune response at the appropriate time (CCF, 2014).  A combination of a viral or 
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bacterial infection and the immune system response not being correctly regulated may 
also cause IBD (CCF, 2014). 
Smoking is an environmental factor that is associated with IBD.  Smoking has 
been seen to be a protective factor for UC development in adults (Lunney et al., 2015).  A 
protective factor is a characteristic that might help prevent the development of a disease 
(Substance Abuse and Mental Health Services Administration, 2018).  This means that 
smokers are less likely to develop UC (Lunney et al., 2015).  Conversely, smoking has 
been seen as detrimental to CD development in adults, meaning that smokers are more 
likely to develop CD (Lunney et al., 2015).  The effect of secondhand smoke (SHS) 
exposure on the development of IBD has not been thoroughly analyzed.  The published 
literature does not show the effect of SHS exposure during childhood on the development 
of IBD (Özbeyli et al., 2017).  I conducted this study to fill in this gap by focusing on the 
development and diagnosis of IBD and the association with exposure to SHS during 
childhood. 
The problem introduced above is meaningful because it will help fill a gap in the 
current literature.  Researchers have examined the effect of smoking on the development 
of UC and CD.  Logically, the next step might be to explore the possible effects that SHS 
exposure can have on the development of IBD since SHS exposure is known to be 
harmful to individuals.  It is crucial to examine the effect of SHS exposure during 
childhood on the development of IBD to determine if the same effect exists when 
exposed to active smoking.  The results of this study could help in the determination of 
additional factors that might cause IBD since the exact causes are still unknown even 
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though it is known that the causes are multifactorial.  The findings of this study can 
positively affect public health by providing additional information regarding IBD that 
could be used to help promote better diagnostics and further research, which may one day 
lead to a cure. 
In this chapter, I explain the background of IBD and smoke exposure as well as 
highlight the gap in the literature regarding the lack of research on childhood SHS 
exposure and IBD.  The problem statement, purpose of the study, research questions, and 
hypotheses are discussed.  The theoretical framework and the nature of the study are also 
introduced.  Lastly, I address the assumptions, scope and delimitations, limitations, and 
significance of this study. 
Background 
IBD research remains an understudied topic, but the amount of research 
evaluating characteristics of IBD has increased over the years.  However, some areas of 
IBD research, such as pediatric research, are limited, with few studies examining this 
group.  Therefore, research on adults marks the possible outcomes within children, but 
more research needs to be conducted with IBD and children since they are more 
vulnerable than adults. 
The literature has shown that cigarette smoking may have a protective effect on 
the development of UC because smokers are less likely to develop UC compared to 
nonsmokers (Daniluk et al., 2017; Özbeyli et al., 2017).  However, smoking tends to have 
a detrimental effect or association with CD because smokers are more likely to 
development CD compared to nonsmokers (Daniluk et al., 2017).  Smoking is also 
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associated with disease progression, determination of surgery, and its outcomes for both 
UC and CD (Lunney et al., 2015).   
The experiences and environments that a child encounters and lives in during 
early life can have an impact on their risk of developing UC and CD; the environment 
includes exposure to smoke through SHS (Guo et al., 2014).  The trend of pediatric cases 
of IBD has been increasing, so it is only logical that the environment (such as SHS 
exposure) would be a good starting point to assess for associations between SHS 
exposure and IBD development in children as well as with a variety of other factors 
(Benchimol et al., 2017). 
The purpose of this study was to examine the association between childhood SHS 
exposure, the development of IBD, and the age of diagnosis.  Earlier research did not 
focus on the association between childhood SHS exposure and the development and 
diagnosis of IBD.  If the results are statistically significant, then there may be an 
association between childhood SHS exposure and the development of IBD as well as an 
association between childhood SHS exposure and the age of diagnosis for those 
diagnosed with IBD. 
Problem Statement 
The purpose of this study was to examine the association between childhood SHS 
exposure, the development of IBD, and the age of diagnosis.  Smoking has decreased 
within the past decade; however, the number of younger individuals diagnosed with UC 
and CD have increased (Benchimol et al., 2017; Centers for Disease Control and 
Prevention [CDC], 2018c; Moran, 2017).  Due to the decrease in the number of smokers, 
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the amount of SHS exposure has also decreased since active smoking leads to passive 
smoke exposure (CDC, 2017).  Based on the associations of active smoking and IBD 
development, the literature has shown that UC and CD may have an inverse relationship 
with SHS exposure (Lunney et al., 2015).  Specifically, active smoking has shown a 
decrease in UC cases and an increase in CD cases (Lunney et al., 2015).  It is reasonable 
to believe that a similar inverse relationship exists between SHS exposure and IBD 
development.  In this study, I further examined the relationship on the development of 
these two IBDs and SHS exposure since only minimal research has been conducted on 
this specific association. 
Purpose of the Study 
In this study, I evaluated this gap in public health concerning the relationship 
between childhood SHS exposure and IBD development using a quantitative approach.  
Secondary data with childhood SHS exposure and disease diagnosis of patients (i.e., UC, 
CD, or no IBD disease) were used to examine this association.  This potential association 
was further addressed using the variable of age at diagnosis.  The primary independent 
factor analyzed was childhood SHS exposure (i.e., exposed or not exposed).  The 
dependent factors examined were disease diagnosis (i.e., UC, CD, or non-IBD) and age at 
diagnosis (i.e., grouped into three categories based on the Montreal classification: 16 
years old and younger, 17–40 years old, and over 40 years old).  I controlled for 
demographic variables (i.e., sex and race), genetic-related variables (i.e., relatives’ IBD 
disease diagnosis), and environment-related variables (i.e., place of residence during 
childhood, were you breastfed as infant, daycare attendance as a child, having pets 
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growing up, were you born via C-section, were you born prematurely, and did you take 
antibiotics before age 1).   
Research Questions and Hypotheses 
RQ1: What is the association between childhood SHS exposure and the 
development of IBD after controlling for demographic (i.e., sex and race), 
genetic, and environmental factors? 
H01: There is no statistically significant association between childhood 
SHS exposure and the development of IBD after controlling for 
demographic, genetic, and environmental factors. 
Ha1: There is a statistically significant association between childhood SHS 
exposure and the development of IBD after controlling for demographic, 
genetic, and environmental factors. 
RQ2: What is the association between childhood SHS exposure and the age at 
diagnosis for those who have IBD after controlling for demographic (i.e., sex and 
race), genetic, and environmental factors? 
H02: There is no statistically significant association between childhood 
SHS exposure and the age at diagnosis for those who have IBD after 
controlling for demographic, genetic, and environmental factors. 
Ha2: There is a statistically significant association between childhood SHS 
exposure and the age at diagnosis for those who have IBD after controlling 
for demographic, genetic, and environmental factors. 
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Theoretical Foundation 
The theoretical framework for this study was Bronfenbrenner’s ecological 
systems theory.  This theory postulates that the environments in which a child lives, as 
well as the inherent qualities of that child, determine the growth and development of that 
child (The Psychology Notes Headquarters, 2013).  This approach consists of examining 
the multiple environments (or systems) in which a child lives: microsystem (i.e., 
immediate environment), mesosystem (i.e., connections), exosystem (i.e., indirect 
environment), macrosystem (i.e., social and cultural values), and chronosystem (i.e., 
changes over time; The Psychology Notes Headquarters, 2013).  The microsystem 
includes entities that are the most influential on the life of the child since the child 
interacts with these the most; these entities include, but are not limited to, school, 
daycare, and family (Paquette & Ryan, n.d.).  The chronosystem consists of the element 
of time and how the development of the child can change over time based on the child’s 
environment and their reaction to the environment (Paquette & Ryan, n.d.).  While the 
theory itself consists of more environments, I focused only on the microsystem and the 
chronosystem in this study. 
Nature of the Study 
The nature of this study was quantitative.  A quantitative research method allows 
for the comparison or correlation of population attributes and the generalization of results 
to populations (Creswell, 2013).  I developed the research questions for this study to 
examine the associations between childhood SHS exposure, IBD development, and age 
of diagnosis.  Secondary data from the National Institutes of Health Integrative Human 
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Microbiome Project: The Inflammatory Bowel Disease Multi’omics Database 
(IBDMDB) were used to examine this association.  Multinomial logistic regression was 
used to determine the association between the independent and dependent variables.  The 
independent variable was childhood SHS exposure, and the dependent variables were 
IBD diagnosis for RQ1 and age at diagnosis for RQ2. 
Definitions 
Age at diagnosis: The age (in years) at which an individual was diagnosed with 
IBD through the careful examination of signs, symptoms, exams/procedures, and tests 
(National Cancer Institute at the National Institutes of Health [NCI at NIH], n.d.). 
Childhood secondhand smoke (SHS) exposure: Exposure during childhood to 
smoke in the environment that came from another individual using tobacco products 
(NCI at NIH, n.d.). 
Crohn’s disease (CD): A type of IBD that can affect the entire gastrointestinal 
(GI) tract, especially the small intestine and colon (CCF, 2014; NCI at NIH, n.d.). 
Inflammatory bowel disease (IBD): A category of chronic inflammatory diseases 
that includes CD and UC that result in inflammation of the GI tract, which can lead to 
symptoms, such as abdominal pain, constipation, diarrhea, rectal bleeding, loss of 
appetite, weight loss, fatigue, urgency to use the restroom, etc.; the exact cause of IBD is 
unknown, and there is no known cure (CCF, 2019b; NCI at NIH, n.d.). 
Ulcerative colitis (UC): A type of IBD that only affects the colon (CCF, 2014; 
NCI at NIH, n.d.). 
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Assumptions 
I made a handful of assumptions that were essential for this study to be 
conducted.  First, it was assumed that the data set being used followed the characteristics 
of a normal distribution due to the Central Limit Theorem, which states that a sample size 
of 30 or more can be assumed to be large enough to follow a normal distribution (Kwak, 
& Kim, 2017).  The data set that was used contained 74 patients who met the inclusion 
criteria for this study.  This assumption of a normal distribution was critical in the 
selection of the most appropriate statistical method to use for data analysis.  There were 
also limited secondary data sources available that contained the necessary variables for 
the completion of this study.  
Second, I assumed that the diagnosis of IBD was determined by a qualified 
physician (i.e., gastroenterologist) through the use of colonoscopy and analysis of 
histological samples, if relevant.  This was important to assume because a self-diagnosis 
based on symptoms, a diagnosis by an unqualified physician, or a diagnosis without a 
colonoscopy cannot be definitive. 
Scope and Delimitations 
One delimitation of this study was participation in the IBDMDB.  Patients also 
had to meet the inclusion criteria of childhood SHS exposure and patient IBD status.  If 
information regarding childhood smoke exposure and development and diagnosis of IBD 
(or not) were not collected, then the patients were not included in the study due to these 
factors being the primary variables required for the research questions to be answered.  
Due to the limited patients involved in this data set, the results of this study have a 
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limited generalizability to the general population because results are only relevant (i.e., 
not statistically significant) to those individuals included. 
Bronfenbrenner’s ecological systems theory aided me in the development of this 
study because this theory has been used for a variety of studies regarding children and 
how their environments affect disease progression over time (see The Psychology Notes 
Headquarters, 2013).  I considered using the concept nicotine replacement therapy for 
this study; however, this concept did not quite fit the needs of this study because most 
quantitative research is formed based on theory instead of a concept. 
Limitations 
I identified several limitations for this study.  One limitation was the use of 
secondary data; this can be considered a limitation since the data were not necessarily 
collected for answering the specific research questions of this study, and I was not 
involved in the actual collection of the data, so I do not have a clear understanding of 
how the data collection process was conducted (Cheng & Phillips, 2014).  Another 
limitation was that the specific geographic regions where the patients live are unknown, 
so I was not be able to control for the geographic area in this study.  A third limitation 
was not being able to examine additional variables that might be of interest, such as SHS 
exposure during pregnancy, paternal versus maternal SHS exposure, and the length of 
time exposed to SHS during childhood.  These variables could potentially be addressed in 
future research because they were not available for analysis within the chosen data set.  A 
final limitation was the small sample size; this could not be prevented because there are 
limited data available that directly relates to the research questions.  However, the Central 
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Limit Theorem states that the number of patients available is sufficient enough (Kwak & 
Kim, 2017). 
Significance 
Research for IBD has increased in the past years, but there is still less research 
being conducted for this disease when compared to some other conditions that may affect 
a greater percentage of the population, such as cancer.  The findings of this study fill the 
gap in the literature regarding whether SHS exposure during childhood is associated with 
IBD development.  The results from this study, partnered with those of previous 
researchers, may allow public health professionals to be able to predict whether IBD 
would develop based on childhood characteristics, such as the environment (i.e., SHS 
exposure, attending daycare, having pets, etc.) and other influences (i.e., breastfed as an 
infant, born via C-section, born prematurely, and treated with antibiotics before the age of 
1).  This knowledge could lead to better treatment methods and more significant 
preparation for treatment in individuals because the findings of this study may lead to 
future research that may pinpoint which individuals are at a higher risk for developing 
IBD.    
The results of this study might also lead to future studies that evaluate additional 
risk factors for the development of IBD.  The ability to determine an individual’s risk for 
developing a disease is an essential aspect of epidemiology (CDC, 2006).  At the 
individual level, knowing the personal risk of disease can lead to individuals taking 
preventive actions to eliminate or reduce their risk of developing the disease.  At the 
community level, policies can be enacted, which may help prevent the development of 
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IBD and focus on increasing public health regarding GI diseases.  At the clinical level, 
additional risk factors can be evaluated, which may help physicians better diagnose and 
treat the health of the public with IBD. 
Summary 
Even though research involving IBD has increased over the years, the association 
between childhood SHS exposure and the development and diagnosis of IBD has not 
been adequately examined.  In this chapter, I provided the background of IBD and 
smoking to create a platform from which to expand research to childhood SHS exposure 
and IBD development and diagnosis.  This critical research was introduced and supported 
by providing an overview of previous related literature.  The problem statement and 
purpose of the study were discussed.  I also presented the research questions and 
hypotheses as well as the theoretical foundation, nature of the study, essential definitions, 
assumptions, scope and delimitations, limitations, and significance. 
In Chapter 2, I will provide a detailed review of current and previous literature 
related to the research questions and topic as well as specify the gap that this research 
study aimed to fill.  Topics discussed will include a background of IBD development and 
diagnosis, the observed associations between active smoking and IBD development, 
research involving children and IBD, and analysis concerning the theoretical foundation 
of the study. 
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Chapter 2: Literature Review 
Introduction 
IBD is a group of chronic, autoimmune diseases that affect over 3 million people 
(CCF, 2014).  Within the past decade, more children have been diagnosed with IBD than 
previous decades (Benchimol et al., 2017; Moran, 2017).  Since smoking is associated 
with the development of IBD, it is crucial to examine the effects of SHS on the 
development of IBD in children (Lunney et al., 2015).  Of what is known of the 
associations seen between IBD and smoking, it is reasonable to believe that SHS 
exposure will have the same effect on IBD, meaning that secondhand smoking will have 
a protective effect on UC and be detrimental to CD development (Lunney et al., 2015). 
Because the number of younger individuals being diagnosed with IBD has 
increased while smoking has decreased, the purpose of this study was to examine the 
association between childhood SHS exposure, the development of IBD, and the age of 
diagnosis.  There is limited research regarding the association of SHS exposure and the 
development of IBD in children; therefore, I examined this potential association in this 
study to try to gain some insight regarding these variables, which could lead to a better 
understanding of SHS and early life exposure and its potential role in the development of 
IBD in children.  This study could be an essential step in determining possible causes of 
these diseases because their origins are not entirely known (see CCF, 2014). 
In this literature review, I sought to examine the basis for the intended association 
for this research.  In this chapter, I examine Bronfenbrenner’s ecological systems theory 
and the reasoning behind why this theory is acceptable to use for this association.  The 
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key factors that may play a role in the association between childhood SHS exposure and 
the development of IBD are also identified and explored.  I expound upon what is known 
regarding IBD, including the relationship between smoking and IBD development in 
adults and other childhood or early-life exposures, in an attempt to provide the 
information needed to proceed with the current study. 
Literature Search Strategy 
I located the extant literature for this review through searches of the following 
databases: MEDLINE and CINAHL combined, EBSCO, PubMed, Science Direct, and 
Google Scholar.  The focus was on literature published in the last 5 years, but some 
pertinent information had to be obtained from older documents.  The keyword search 
terms used included inflammatory bowel disease, IBD, ulcerative colitis, UC, Crohn’s 
disease, CD, children, childhood exposures, smoking, secondhand smoking, 
Bronfenbrenner’s ecological systems theory, disease, and several combinations of these 
terms. 
Theoretical Foundation 
Since this study was involved with the development of a disease based on 
childhood exposures, I used Bronfenbrenner’s ecological systems theory as the 
theoretical foundation.  Bronfenbrenner first authored this theory in a book, The Ecology 
of Human Development: Experiments by Nature and Design, published in 1981.  
However, Bronfenbrenner developed the ecological systems theory mostly in 1979 with 
the addition of the chronosystem in 1986, partly based on the author’s influence on and 
participation in the Head Start Program (“Ecological systems theory,” 2018).  
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Bronfenbrenner (1981) stated that the environment plays a crucial role in the growth and 
development of a child, including the development of disease.  There are five levels of 
the environment in which a child lives: microsystem, mesosystem, exosystem, 
macrosystem, and chronosystem (“Ecological systems theory,” 2018).    
Bronfenbrenner’s ecological systems theory is based on the premise that the 
interaction of the child and these five environments influence the child’s development 
(“Ecological systems theory,” 2018).  While this theory does not provide real solutions to 
health problems, the examination of these five different environmental systems can lead 
to determining the potential cause of a health problem since all possible variables are 
examined throughout all the systems (“Ecological systems theory,” 2018).  The 
microsystem consists of the child and all of his or her interactions with family members, 
friends, and other relevant individuals, such as teachers, who together encompass the 
child’s immediate environment (“Ecological systems theory,” 2018; Paquette & Ryan, 
n.d.; The Psychology Notes Headquarters, 2013).  The microsystem can also affect the 
development of the child’s habits and temperaments, which may stay with him or her for 
life (“Ecological systems theory,” 2018).  The mesosystem represents the connections or 
relationships between the child’s different microsystems, such as parents and teachers 
interacting (“Ecological systems theory,” 2018; The Psychology Notes Headquarters, 
2013).  The exosystem involves the child’s indirect environment, which can affect the 
child and his or her microsystem, but the child does not influence it (“Ecological systems 
theory,” 2018; The Psychology Notes Headquarters, 2013).  The exosystem can include 
the neighborhood, the local community, and health and social services as well as local 
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businesses and media (“Ecological systems theory,” 2018).  The macrosystem consists of 
the culture/subculture, social class, ethnic group, and religious affiliations that surround 
the child (“Ecological systems theory,” 2018; The Psychology Notes Headquarters, 
2013).  These entities may change over time, and the child may play a small part in these 
changes; the changes can affect the child’s values and beliefs (“Ecological systems 
theory,” 2018).  The outermost level, the chronosystem, includes the element of time and 
how the development of the child can change over time based on the child’s environment 
and their reactions to and interactions with the environment (“Ecological systems 
theory,” 2018; Paquette & Ryan, n.d.; The Psychology Notes Headquarters, 2013). 
This theory has been used previously in social work, education, psychology, 
policymaking, and public health (“Ecological systems theory,” 2018).  Zhou and Cheah 
(2015) examined the possible health risks that may lead to obesity in Chinese American 
children using this theory since this population is typically left out of the obesity 
equation; the authors created a pathway that may help further research for this population.  
Graves and Sheldon (2017) used Bronfenbrenner's ecological systems theory to highlight 
the potential components that can lead to effective recruitment methods for African 
American youth as well as barriers that may stem from the youths’ interactions with these 
systems.  Additionally, Kekoni, Miettinen, Häkälä, and Savolainen (2019) studied the 
factors affecting child development in foster care using this theory to determine why 
foster children tended to not succeed as well in adulthood compared to those not in foster 
care.  However, I found no articles regarding one specific environmental factor, such as 
SHS exposure, and the development of the disease. 
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Bronfenbrenner’s ecological systems theory focuses on how the environment on 
all levels can affect the growth and development of a child, including the development of 
disease or other health conditions (Paquette & Ryan, n.d.).  In this study, I examined the 
relationship between childhood SHS exposure and the development of IBD due to this 
environmental exposure.  This theory has also been used to highlight the importance of 
considering all potential environmental factors because any factor could have a possible 
effect on the child’s life and, more specifically, health (“Ecological systems theory,” 
2018).  I developed RQ1 to inquire whether childhood SHS exposure could be associated 
with the development of IBD.  Additional environmental factors were taken into 
consideration as possible covariates to ensure that any association seen was from 
childhood SHS exposure alone.  RQ2 addresses if there is a relationship between SHS 
exposure and age of diagnosis while also considering other environmental factors that 
could affect any potential associations.  The levels of the environment that were 
examined in this study were the microsystem and chronosystem.  Only these two levels 
were considered because any possible SHS exposure would only be relevant if it was 
continuous, meaning that it would have to happen around the child often, so it makes 
sense that the exposure would occur in the child’s immediate environment (i.e., 
microsystem), and then the disease outcome is what happens over time (i.e., 
chronosystem). 
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Literature Review Related to Key Variables 
Inflammatory Bowel Disease (IBD) 
IBD is a type of classification for the two primary diseases it encompasses: UC 
and CD (CCF, 2014).  Both of these diseases result from inflammation in the GI tract 
(CCF, 2014).  UC involves only inflammation of the colon and sometimes the rectum, 
whereas the inflammation involved in CD can appear in any part of the GI tract from the 
mouth to the anus (CCF, 2014; Gajendran, Loganathan, Catinella, & Hashash, 2018).  
UC tends to cause inflammation in a particular section, and it is continuous (CCF, 2014).  
In contrast, there can be alternating affected (i.e., inflamed) and nonaffected areas for CD 
(CCF, 2014).  This difference between the appearance of UC and CD allows for doctors 
to evaluate and diagnose UC based solely on colonoscopy results partnered with 
symptoms and histological samples (if taken or if available).   
Causes 
Researchers do not entirely understand the mechanisms behind the development 
of IBD; the causes are understood to be a combination of hereditary factors, genetics, the 
immune system responses, and the environment (CCF, 2014).  Gajendran et al. (2018) 
stated that CD risk factors include smoking, low fiber-high carbohydrate diet, altered 
microbiome, and medications such as nonsteroidal anti-inflammatory drugs. 
Genetics play a role in the development of IBD; if an individual has a first-degree 
relative with IBD, then that individual is 10 times more likely to develop IBD compared 
to those individuals without a first-degree relative with IBD (Orholm et al., 1991).  Five 
to 20% of IBD patients have a first-degree relative with IBD (CCF, 2014).  Those 
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individuals with a second degree relative with IBD also have an increased risk of 
developing IBD, but it is a lot lower than with a first-degree relative (Orholm et al., 
1991).  Children who have mothers with CD have an increased risk of developing CD, 
especially if the mother was over the age of 35 years old and a smoker (Orholm et al., 
1991).  According to Mikhailov, Christensen, and Furner (2017), family history of UC is 
a risk factor for the development of CD, but a family history of CD is a protective factor 
for the development of CD.   
Conflicting information regarding whether diet influences the development of 
IBD has been observed in research, but more research is needed to determine the exact 
contribution that diet may or may not have on the development and progression of IBD 
(CCF, 2014).  Voutilainen et al. (2018) examined the relationship between early life 
exposures and the development of IBD later in life (within a 34-year follow-up period).  
Low high density lipoprotein cholesterol levels during childhood were correlated with the 
development of IBD; an inverse relationship between c-reactive protein concentrations 
during childhood and the development of IBD was also observed (Voutilainen et al., 
2018).  Diets high in sucrose before diagnosis have been associated with a higher risk of 
IBD development (Reif et al., 1997).  An increase in the risk of UC was associated with 
high amounts of trans-unsaturated fats, while a decrease in the risk of UC was associated 
with high amounts of dietary long-chain n-3 polyunsaturated fatty acids 
(Ananthakrishnan et al., 2014). 
IBD involves the patient’s immune response continuing long after it should stop 
because it misclassifies food, bacteria, and other substances as foreign and, therefore, 
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proceeds to attack the healthy cells, which causes inflammation (CDC, 2018b).  Changes 
in gut microbiota can lead to nonspecific gut inflammation, which can lead to IBD in 
those individuals with genetic susceptibility (Abegunde, Muhhamad, Bhatti, & Ali, 
2016). 
However, it is possible that medications can affect IBD development.  Antibiotic 
exposure has been seen to be associated with new CD development but not UC (Ungaro 
et al., 2014).  Disease activity is not altered by oral contraceptives (Cosnes, Carbonnel, 
Carrat, Beaugerie, & Gendre, 1999).  A 3 times increase in flares was observed with CD 
patients who continued to take oral contraceptives, but smoking could also be a 
confounding variable (Timmer, Sutherland, & Martin, 1998).   
Impact of IBD on Individuals’ Lives 
The age of diagnosis for UC and CD tends to correlate with the reproductive ages 
of 15 to 30 years old (CCF, 2014).  However, more pediatric patients are being diagnosed 
with these diseases at even younger ages, which can have an extreme impact on their 
developmental stages (Benchimol et al., 2017; Moran, 2017).  A child’s height can be 
stunted or slowed as a result of developing one of these diseases during childhood; 
delayed puberty is also possible (CCF, 2014).   
Symptoms of IBD include constipation, diarrhea, the urgency to use the 
bathroom, not knowing whether you will make it to the toilet in time, gas, abdominal 
pain, rectal bleeding, loss of appetite, fatigue, etc. (CCF, 2014).  Childhood is such a 
critical time in an individual’s life with their bodies growing and developing, and 
children are susceptible to other problems, such as emotional issues (i.e., embarrassment, 
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lack of understanding) associated with these diseases (CCF, 2014).  There is no known 
cure for IBD, so a lifetime of care is needed; when this starts at such an early age, it can 
be detrimental to the quality of life of the child (Abegunde, Muhammad, & Ali, 2016).  
The length of time since diagnosis can also determine the probability that a patient will 
require surgery for the disease.  For patients with UC, up to one third will require surgery 
after living with the disease for 30 years (CCF, 2014).  For patients with CD, about 70% 
will require surgery at some point in their lifetime (CCF, 2014).  Thirty percent of these 
CD patients who undergo surgery will have a recurrence of CD within 3 years because it 
is possible for CD to come back in parts of the digestive tract that were not removed 
during surgery (CCF, 2014).  
In addition to living with IBD, some additional health concerns may accompany 
the disease.  Mikhailov et al. (2017) found that patients with IBD were more likely to 
have other illnesses, respiratory diseases, or hospitalizations during infancy than non-IBD 
patients.  IBD patients are also more likely to have the following chronic conditions: 
heart disease, lung disease, cancer, diabetes, arthritis, kidney disease, any liver disease, 
and ulcers compared to those without IBD (CDC, 2018a). 
Anemia. Anemia is an extraintestinal manifestation that is very common in IBD 
patients (Hindryckx, Amininejad, Van De Vijver, & Bossuyt, 2014).  Anemia in IBD 
patients can be caused by a multitude of mechanisms including blood loss from inflamed 
intestinal tissue, nutrient deficiency of iron and B12, chronic inflammation, hemolysis, 
and myelosuppression from medications (Dieleman & Heizer, 1998).    
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Venous thromboembolism. It was found that IBD patients are 3.5 times more 
likely to develop venous thromboembolism compared to sex- and age-matched controls 
(Novacek et al., 2010).  This increased risk could result from a combination of 
malnutrition, heredity factors, surgery and hospitalization, and inflammation from the 
disease (Magro, Soares, & Fernandes, 2014; Novacek et al., 2010).   
Heart conditions. The risk for developing hypertension correlates with an 
increase in obesity and metabolic syndrome as well as the use of medications such as 
corticosteroids and cyclosporine (Seminerio et al., 2015).  IBD is also associated with 
increased risks for several heart conditions such as atrial fibrillation, stroke, myocardial 
infarction, heart failure, and cardiovascular-related death during a flare; there are no 
elevated risks for these heart conditions during remission (Kristensen et al., 2014).  The 
risk of coronary artery disease is slightly higher for IBD patients (Singh, Kullo, Pardi, & 
Loftus, 2015; Singh, Singh, Loftus, & Pardi, 2014).  In IBD patients, young adults (less 
than 50 years old) and women have a higher risk of cardiovascular disease compared to 
older adults (more than 50 years old; Singh et al., 2014).   
Osteoporosis. Osteoporosis is another extraintestinal complication for IBD 
patients (CCF, 2014).  The easiest way to prevent osteoporosis in patients is to reduce the 
number of glucocorticoids taken (Abegunde, Muhammad, & Ali, 2016).   
Sleep deprivation/disturbances. Sleep problems have been associated with IBD 
(Dickstein & Moldofsky, 1999).  Sleep disorders can greatly affect the quality of life for 
those with IBD (Abegunde, Muhammad, & Ali, 2016).  Sleep disturbances can also be 
caused by the medications taken, such as corticosteroids (CCF, 2014).  There is not 
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enough data to mandate treating sleep disorders in IBD patients, but IBD patients should 
be screened for sleep disorders (Abegunde, Muhhamad, Bhatti, et al., 2016).  
Additional medical conditions. Other extraintestinal complications include 
redness, pain, and itchiness of the eyes; mouth sores; joint pain and swelling; tender 
bumps, painful ulcerations, and other sores/rashes of the skin; kidney stones; and primary 
sclerosing cholangitis, hepatitis, and cirrhosis of the liver (CCF, 2014). 
Vaccination. Vaccination is another aspect of health that is even more important 
for individuals with IBD.  Since IBD patients usually have compromised immune 
systems due to medications, these patients must be vaccinated to protect them against 
vaccine-preventable diseases (Chaudrey, Salvaggio, Ahmed, Mahmood, & Ali, 2015; 
Reddy, Beavers, Hammond, Lim, & FalckYtter, 2015). Live vaccines are not 
recommended as there is an increase in infection for immunocompromised IBD patients 
(Chaudrey et al., 2015; Reddy et al., 2015).  All other vaccines should be given before 
beginning immunosuppressive therapy medications, if possible (Chaudrey et al., 2015; 
Reddy et al., 2015).  Exposure to live vaccines through family members is also a concern 
as it places the patient at risk (Chaudrey et al., 2015; Reddy et al., 2015).  However, there 
are some circumstances (such as traveling to foreign countries) when live vaccines may 
be required, or the benefits outweigh the risks, but it is crucial to speak with a doctor to 
determine the best time to receive a live vaccine (Chaudrey et al., 2015; Reddy et al., 
2015). 
Psychology and psychiatry. There may be a psychological component of IBD 
that can affect the patient's well-being and social life.  This may be due to how an 
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individual perceives him or herself as being functionally disabled due to having this 
chronic disease (Irvine et al., 1994; Turnbull & Vallis, 1995).  Also, the chronic nature of 
IBD with alternating stages of remission and flares, along with medication side effects, 
can lead to a person feeling alone and depressed (CCF, 2014).  IBD patients are also 
more likely to experience higher amounts of psychiatric distress, anxiety, alexithymia, 
and somatosensory amplification (Becker et al., 2015).  Due to this, relationships with 
friends, family members, or intimate partners can be negatively affected and result in a 
lower quality of life for the patients (Becker et al., 2015).  Also, stress has been 
associated with an increase of flares in IBD but not an increase in risk for developing 
IBD (Gerbarg et al., 2016).   
Treatments and Care 
Unfortunately, there is no known cause for these diseases, but research shows that 
the causes of these diseases stem from genetic, environmental, and immune system 
components (CCF, 2019a, 2019c).  Those individuals with an immediate family member 
with an IBD are more likely to develop IBD as well (5% to 20% with IBD have a first-
degree relative with IBD) compared to individuals without a family history of IBD (CCF, 
2014).  Those individuals whose parents have been diagnosed with IBD have an even 
higher percentage of developing and being diagnosed with IBD (CCF, 2014). 
Care for IBD patients is more focused on controlling symptoms rather than 
preventing further disease (Abegunde, Muhammad, & Ali, 2016).  Including preventive 
measures may help make the individual’s life more bearable, help plan for what might 
happen, and help catch new signs of disease or complications earlier than without 
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preventive health care.  Preventive care could also lead to better options for patients since 
the disease could be detected earlier, and the disease may be in a less aggressive state.  
Steroids are commonly used to try to induce remission in IBD patients, but they 
are not effective in maintaining remission (Abegunde, Muhammed, & Ali, 2016).  Side 
effects of steroids can be adverse, so limiting the amount of steroid use in IBD patients is 
essential (Abegunde, Muhammed, & Ali, 2016).  Probiotics, in general, have not been 
effective in managing IBD (Sokol, 2014).  However, VSL#3 is effective at inducing 
remission in patients with mild-to-moderate active UC (Sokol, 2014).  VSL#3 has also 
been seen to be beneficial in UC patients who have undergone ileal pouch-anal 
anastomosis (Singh, Stroud, Holubar, Sandborn, & Pardi, 2015).  VSL#3 is a mixture of 
Lactobacillus casei, L. plantarum, L. acidophilus, B. breve, B. infantis, Bifidobacterium 
longum L.delbrueckii subsp. bulgaricus, and Streptococcus salivarius 
subsp.thermophiles, which tends to work better than only single agents/bacteria (Sokol, 
2014).  Additional medications used for the treatment of IBD include 5-aminosalicylic 
acids, thiopurines, methotrexate, anti-TNF-alpha agents, and anti-integrin antagonists.  
With all of these medications, routine lab testing should be conducted to ensure main 
body systems (liver, kidney, etc.) are not negatively affected by the medicines. 
Smoking cessation can be seen as a treatment for those with CD as smoking 
worsens CD (Abegunde, Muhammad, & Ali, 2016).  Smoking cessation reduces the risk 
of CD, disease flares, surgeries, and the number of treatments or medications needed for 
an individual (Nunes et al., 2016).  Smoking cessation is not considered a treatment for 
UC since smoking is a protective factor for UC, but smoking cessation is considered 
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crucial due to the other disastrous effects smoking has on the human body and its position 
as a risk factor for a multitude of other diseases (Abegunde, Muhammad, & Ali, 2016).  
Nunes et al. (2016) stated that it is essential for gastroenterologists and primary care 
physicians to advise their IBD patients who smoke to quit smoking as the number of 
disease relapses (i.e., flares) is less in nonsmokers and those who quit smoking compared 
to current smokers. 
Moderate exercise might help relieve some of the IBD symptoms as well as 
decrease the risk of obesity (Melinder et al., 2015).  Exercise and physical fitness have 
been seen to have an inverse relationship with IBD activity, which points to a protective 
effect of exercise on IBD (Melinder et al., 2015).  Physical activity can help improve the 
quality of life for IBD patients by reducing disease activity; this can make physical 
activity an essential part of therapy/treatment for advancing all facets of IBD patient 
health (Bilski, Brzozowski, Mazur-Bialy, Sliwowski, & Brzozowski, 2014; Klare et al., 
2015).  Diet-based interventions have not been successful in maintaining remission in 
IBD (Ballegaard et al., 1997; González-Huix et al., 1993).     
Smoking and Health in General 
Smoking is “the leading cause of preventable death” worldwide (CDC, 2019, 
para. 2).  Smoking affects almost every system in the body and is well-known for its risks 
of cardiac, respiratory, and oncologic diseases (Abegunde, Muhammad, & Ali, 2016; 
Siquiera, 2017; CDC, 2019). 
Smoking can result in appetite suppression and thus weight loss, but this can turn 
into smokers gaining weight with increased fat deposits and decreased metabolic rates for 
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chronic conditions (long-term smoking; Siquiera, 2017).  Nicotine can negatively affect 
fertility for both men and women and possibly lead to erectile dysfunction; smoking also 
has been seen to have adverse reactions during pregnancy resulting in reduced weight, 
length, and head circumference of the fetus which can lead to long-term effects such as 
obesity, hypertension, Type 2 diabetes, respiratory dysfunction, neurobehavioral effects, 
and impaired fertility as well as “significant impairments in cognitive functioning, 
impulsivity, hyperactivity, an increased risk of developing an addiction disorder” (Bruin, 
Gerstein, & Holloway, 2010; Siquiera, 2017, p. e7). 
Secondhand Smoking and Health in General 
Nicotine (the addictive ingredient) is one of the significant components released 
through smoking and other tobacco products.  Children can be introduced to nicotine 
through all types of tobacco products, including chewing tobacco, cigarettes, pipe 
tobacco, nicotine gum and patches, some insecticides, and now e-cigarettes (Siquiera, 
2017).  If vomiting is induced as a result of these products, then the effects are not severe 
due to the toxins exiting the body (Siquiera, 2017).  However, e-cigarettes have nicotine 
in a liquid form which is more easily taken in a concentrated dose, and, if ingested, this 
can lead to death in children from nicotine poisoning (lethal at levels between 1 and 13 
mg/kg for children and as little as 50 to 60 mg/kg in adults; Siqueira, 2017).  Symptoms 
of nicotine ingestion range from vomiting and nausea to arrhythmias and coma (Siqueira, 
2017). 
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Association Between Smoking and IBD Development 
Research has been conducted regarding active smoking and its association with 
IBD development.  Smoking has been seen to have a protective effect on the 
development of UC and a detrimental effect on the development of CD (Daniluk et al., 
2017).  This means that smokers are less likely to develop UC but more likely to develop 
CD; nonsmokers are at a higher risk of developing UC and a lower risk of developing 
CD.  The protective factor of smoking on UC is very unusual as smoking is typically 
detrimental to all body systems.  Also, smoking is usually a risk factor for the 
development of several diseases and health conditions.  Patients with UC, who are 
current smokers, are more likely to experience a less severe disease course, require fewer 
steroids and other medications, and require fewer hospitalizations (Mokbel, Carbonnel, 
Beaugerie, Gendre, & Cosnes, 1998).  Those individuals who quit smoking before 
disease onset had higher hospitalizations for colectomy (i.e., surgery; Boyko, Perera, 
Koepsell, Keane, & Inui, 1988).  Current smokers have lower relapse rates and colectomy 
occurrences compared to nonsmokers (Boyko et al., 1988). 
On the contrary, smoking can have a negative effect on the development of CD 
(Abegunde, Muhammad, & Ali, 2016).  Mikhailov et al. (2017) evaluated several smoke 
exposures, with many of them acting as risk factors for the development of CD; a 
combination of all smoke exposures was continuously seen as a significant risk factor for 
the development of CD.  Mikhailov et al. consistently found that any amount of smoke 
exposure was associated with the development of CD.  The lack of research regarding 
SHS exposure and IBD development is what has led to this current research study. 
29 
 
Other Childhood Exposures and IBD Development 
Environmental factors can also contribute to the development of IBD and can 
encompass a variety of avenues.  For example, early-life indicators, such as the place 
where you were born or lived (in the United States or outside the United States; rural, 
urban, or suburban; hospital or not) could affect IBD development.  Other early 
influences or factors such as breastfeeding can play a part in the immune response; this is 
still classified as an environmental exposure as it is a factor being introduced to the 
individual from outside of the body.  Something as simple as whether the child was 
exposed to having a pet in the house could also affect the development or 
nondevelopment of IBD.  There is a multitude of influences or factors that can impact the 
potential of future disease development.  SHS exposure is an environmental factor for 
which I have not found any data, but it is possible that this could be associated with the 
development of IBD as well. 
There are conflicting results regarding breastfeeding and association with IBD; 
some studies say that breastfeeding is protective while others say there is no association, 
and, still, others name breastfeeding as a risk factor for IBD development (Ekbom, 
Adami, Helmick, Jonzon, & Zack, 1990).  Guo et al. (2014) found that those individuals 
with CD who were breastfed were less likely to have surgery related to their disease 
while those individuals who experienced childhood SHS exposure were more likely to 
have to undergo CD-related surgery.  These associations were correct when controlling 
for age at diagnosis, disease duration, location of disease, disease behavior, the presence 
of perianal disease, and current smoking status (Guo et al., 2014).  However, when 
30 
 
examining the influences of breastfeeding and SHS exposure simultaneously, only 
breastfeeding was found to be significant and associated with a decreased risk of disease-
related surgery (Guo et al., 2014).  On the contrary, Mikhailov et al. (2017) found no 
statistically significant association between being breastfed as an infant and the 
development of CD; however, a nonsignificant protective effect was observed with 
breastfeeding and the development of CD.  Additionally, a longer duration of 
breastfeeding tended to have a more significant protective effect on the development of 
CD (Mikhailov et al., 2017).  
Being diagnosed at an older age was associated with less risk of surgery for CD 
while having pets, growing up on a farm, or going to daycare were not associated with 
risk for CD-related surgery (Guo et al., 2014).  Guo et al. (2014) found no association for 
risk of UC-related surgery when examining early life exposures. 
Some research suggests that vitamin D may play an active role in disease activity 
for IBD (Basson, Swart, Jordaan, Mazinu, & Watermeyer, 2016; Del Pinto, Pietropaoli, 
Chandar, Ferri, & Cominelli, 2015; Holmes, Xiang, & Lucas, 2015).  However, there are 
conflicting results about vitamin D and its potential effect on IBD development and 
disease course.  Geographic location was suggested by some to be a factor of IBD 
development.  Those living in more northern latitudes have a higher incidence of IBD 
compared to southern latitudes due to different amounts of exposure to UV light (Del 
Pinto et al., 2015; Holmes et al., 2015); others have not seen this relationship.  While 
more information is needed to determine the extent of the association of vitamin D 
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deficiency and IBD, it is essential to test levels of vitamin D in IBD patients (Abegunde, 
Muhammad, Bhatti, et al., 2016). 
Summary and Conclusions 
The exact nature of IBD origins has not been identified.  However, it is known 
that the environment, genetics, and immune system response all play a part in the 
development of IBD.  The diagnosis of IBD forever changes the life of an individual; this 
includes the individual being more susceptible to other diseases or health conditions as 
well as the individual's social life.  There is no known cure for IBD, although there is a 
wide range of treatments from antibiotics to immunosuppressants to biologics to surgery. 
Smoking is an environmental factor that has been continuously examined with 
regards to IBD.  Smoking has been associated with IBD development and disease 
progression, with smoking being detrimental for CD development but protective against 
UC development.  However, SHS exposure on the development of IBD in children has 
not been thoroughly examined.  This current study aims to lessen this gap by examining 
the relationship between disease diagnosis and childhood SHS exposure.  Conducting this 
research may lead to more knowledge regarding early life exposures and IBD diagnosis.  
In Chapter 3, I will describe the research design and rationale, methodology, and threats 
to validity for this study. 
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Chapter 3: Research Method 
Introduction 
The cause of IBD is known to be multifactorial; even though the exact specifics 
are still unknown, the environment is one of the critical factors in IBD development 
along with genetics and the immune system response (CCF, 2014; Moran, 2017).  With 
the environment factoring into the causal equation, it is crucial to investigate early life 
exposures, especially when individuals are diagnosed during childhood.  One specific 
environmental, early-life exposure comes from the introduction to SHS during childhood.  
While research exists regarding smoking and IBD development in adults, little is known 
regarding childhood SHS exposure and the development of IBD in children.  Evaluating 
this potential relationship could lead to insights regarding whether SHS exposure has the 
same effect on the development of IBD as smoking does.  In this chapter, I describe the 
research design and rationale, methodology, and threats to validity for this study. 
Research Design and Rationale 
Quantitative research methods involve the gathering and managing of numerical 
data to describe a phenomenon and be able to generalize it to a broader population (USC 
Libraries, 2019).  Quantitative research aims to evaluate the relationship between two or 
more variables using numerical data and statistical tests (USC Libraries, 2019).  
Quantitative research can be either descriptive/observational or experimental depending 
on what type of data are collected; observational studies aim to evaluate the relationship 
or associations between variables, while experimental studies aim to determine causality 
between the variables (USC Libraries, 2019).  In this current study, I conducted an 
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observational study in which the relationship between childhood SHS exposure and IBD 
development was evaluated.  The independent variable was childhood SHS exposure, 
while the dependent variable for RQ1 was the disease diagnosis of patients and the 
dependent variable for RQ2 was the age at diagnosis.  Additional covariates in this study 
were demographic variables (i.e., sex, race), genetic-related variables (i.e., relatives’ IBD 
disease status), and environmental variables (i.e., were you breastfed as an infant, daycare 
attendance as a child, having pets growing up, did you take antibiotics before age 1, were 
you born via C-section, and were you born prematurely). 
I employed a cross-sectional research design in this study.  The cross-sectional 
study design is frequently used in health promotion and when the researchers intend to 
observe the health conditions at one specific time (Salazar, Crosby, & DiClemente, 
2015).  A cross-sectional design can be used to detect differences between patients or 
phenomena, such as an exposure to a health risk or the presence of a health condition 
(Salazar et al., 2015).  Additionally, a cross-sectional design can be useful for assessing 
the association between a risk or protective factor and a health-related outcome (Salazar 
et al., 2015).  A cross-sectional design was appropriate for this study because the 
association between childhood SHS exposure and IBD diagnosis was evaluated. 
Secondary data analysis can be used in quantitative research to gain knowledge 
regarding a similar yet unique topic for which the data were initially gathered (USC 
Libraries, 2019).  I conducted a secondary data analysis in this study using data from the 
IBDMDB.  Using secondary data for this study allowed me to review data already 
collected from patients with an IBD diagnosis.  Use of this secondary data also supported 
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the examination of data from individuals of all ages and provided access to additional 
variables that may have been more difficult to collect.  Using a cross-sectional design 
allowed me to investigate the relationship between childhood SHS exposure and disease 
diagnosis and possibly aid in the foundation of future intricate and complex studies (see 
Salazar et al., 2015). 
Methodology 
Population 
The target population for this study was children and adults of all ages with and 
without an IBD diagnosis who were or were not exposed to SHS during childhood.  I 
retrieved the data for this study from the IBDMDB.  All races, sexes, and ages were 
accepted as participants, but these variables were controlled for within the statistical 
analysis along with other covariates. 
Sampling and Sampling Procedures 
 I used a convenience sample sampling strategy in this study.  Since the data were 
collected from a preexisting database, there was a limit to the amount of data from 
patients that could be gathered.  This made a convenience sampling strategy appropriate 
for this study.  Inclusion and exclusion factors determined the exact data that were able to 
be used from this database for this study. 
Data from IBDMDB consists of 5,333 entries (some are duplicates).  Inclusion 
and exclusion factors considerably lowered this number to 74 participants for this study.  
Inclusion criteria included the following: a response to a diagnosis of IBD (i.e., CD, UC, 
or non-IBD) and an answer to the question, “Were you exposed to cigarette smoke as a 
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child?”  Additionally, age at diagnosis was an inclusion criterion for those individuals 
diagnosed with CD or UC.  Individuals with a diagnosis of non-IBD but not an age at 
diagnosis were still included in analysis related to RQ1 (but not to RQ2).  Exclusion 
criteria were nonresponses to the disease diagnosis and childhood SHS exposure 
variables.  I also considered a nonresponse to age at diagnosis an exclusion factor for 
those individuals with UC or CD. 
I performed a power analysis to determine the desired sample size for this study 
using G*Power Version 3.1.9.2.  The selected parameters used to calculate the sample 
size were as follows: a power of 0.80 (80%), an alpha level of 0.05, and an odds ratio of 
2.48.  Given these parameters, the desired sample size for a two-tailed logistic regression 
test was 71.  A power of 80% was chosen because this is a standard level of power used; 
also, 80% power means that there was an 80% probability that I would not commit a 
Type II error or fail to reject the null hypothesis when it should be rejected (see Statistics 
Solutions, 2019).  An alpha level of 0.05 was chosen because this is the most commonly 
used alpha level; this means that there was a 5% chance of making a Type I error or 
rejecting the null hypothesis when I should have failed to reject the null hypothesis.  I 
used an odds ratio of 2.48 because this is suggested as an appropriate odds ratio to obtain 
a large effect size for logistic regression (see Statistics Solutions, n.d.).  
Archival Data 
The data for this study came from IBDMDB.  This database was formed by 
collecting data from the following established longitudinal cohorts: The Prospective 
Registry in IBD Study at Massachusetts General Hospital, The Pediatric Inception Cohort 
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at Cincinnati Children’s Hospital and Emory University, The Mucosal-Luminal Interface 
(MLI) Cohort at Cedars-Sinai Medical Center, and The Swedish Twins (i.e., the Swedish 
Twin Cohort and Swedish Longitudinal Cohort).  The Prospective Registry in IBD Study 
at Massachusetts General Hospital is a cohort within the Crohn’s and Colitis Center at 
Massachusetts General Hospital that continually enrolls patients who are referred by their 
physicians; this cohort was used to recruit 24 adults (over the age of 18 years old) who 
were newly diagnosed with IBD and not familiar with treatments and six age-matched 
healthy controls into the IBDMDB (n.d.).  The Pediatric Inception Cohort is a cohort that 
comes from the Crohn’s and Colitis Foundation RISK study, which recruits pediatric 
patients with suspected IBD prior to colonoscopic examination and therapy; this cohort 
was used to recruit 24 children who were newly diagnosed with IBD and not familiar 
with treatments and six age-matched healthy controls (IBDMDB, n.d.).  The MLI cohort 
is a cohort at the Cedars-Sinai IBD Center, which recruits patients who are about to 
undergo a clinically-indicated endoscopy; this cohort was used to recruit 24 adults who 
had been diagnosed with IBD more than 5 years before enrollment in the MLI cohort and 
six age-matched healthy controls (IBDMDB, n.d.).  The Swedish Twin Cohort recruited 
twins of the same sex aged 18 years or older to use as a basis for proving the IBDMDB’s 
principle, and the Swedish Longitudinal Cohort recruited both men and women (not 
pregnant or breastfeeding) with IBD; it was not stated how much data were gathered from 
these cohorts to use as a baseline (IBDMDB, n.d.). 
I was able to access the database through the IBDMDB website (ibdmdb.org).  I 
was then be able to click the “Download Data” link, which led me to the Results page 
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where I was able to download the data in an Excel sheet.  This data are publicly available, 
so permission to access the data was not needed.  Because the National Institutes of 
Health compiled this database, I considered the data to be reputable. 
Data Analysis Plan 
The software program I used for the statistical analysis in this study was IBM 
Statistical Package for the Social Sciences (SPSS) Statistics 25.  SPSS was used to 
conduct multinomial logistic regression to assess the relationship between childhood SHS 
exposure (i.e., the independent variable) and the development of IBD (i.e., a dependent 
variable).  SPSS was also used to conduct multinomial logistic regression to assess the 
relationship between childhood SHS exposure (i.e., the independent variable) and age at 
diagnosis (i.e., a dependent variable) for those with IBD.   
Because I used a secondary data set for this study, some data cleaning and 
screening was needed.  After the inclusion and exclusion factors were used to narrow 
down the data set, additional cleaning and screening were needed because there were 
multiple entries for the same patients (at different visits), so it looked like there were a 
greater number of patients than there was.  Removing these duplicate entries was 
important because they would have provided duplicate data points and would have 
skewed the results.  In addition, all missing data were coded as 999 in order for SPSS to 
be able to recognize this data as such.  
The research questions and hypotheses for this study were: 
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RQ1: What is the association between childhood SHS exposure and the 
development of IBD after controlling for demographic (i.e., sex and race), 
genetic, and environmental factors? 
H01: There is no statistically significant association between childhood 
SHS exposure and the development of IBD after controlling for 
demographic, genetic, and environmental factors. 
Ha1: There is a statistically significant association between childhood SHS 
exposure and the development of IBD after controlling for demographic, 
genetic, and environmental factors. 
RQ2: What is the association between childhood SHS exposure and the age at 
diagnosis for those who have IBD after controlling for demographic (i.e., sex and 
race), genetic, and environmental factors? 
H02: There is no statistically significant association between childhood 
SHS exposure and the age at diagnosis for those who have IBD after 
controlling for demographic, genetic, and environmental factors. 
Ha2: There is a statistically significant association between childhood SHS 
exposure and the age at diagnosis for those who have IBD after controlling 
for demographic, genetic, and environmental factors. 
I performed descriptive statistics to define the characteristics of the sample.  
Frequencies and percentages were reported for categorical variables.  All variables, 
including covariates, were categorical in this study.  Childhood SHS exposure was 
defined as the individual being exposed to cigarette smoke as a child.  I defined disease 
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diagnosis as the individual being diagnosed with UC, CD, or non-IBD.  Age at diagnosis 
was the age at which the individuals with UC or CD were diagnosed.  Sex was defined as 
an individual being male or female.  I defined race as the race of an individual.  
Relatives’ disease diagnosis was defined as having a relative (i.e., parent, sibling, 
grandparent, or distant relative) with IBD.  I defined breastfed as an infant as an 
individual being breastfed as an infant.  Daycare attendance was defined as an individual 
attending daycare as a child, while having pets growing up was defined as an individual 
growing up with a pet or not.  I defined born via C-section as an individual being born via 
C-section or not and born prematurely as an individual being born prematurely.  
Antibiotics before the age of 1 was defined as being treated with antibiotics before the 
age of 1.  These covariates have been researched in the literature and were shown to have 
some type of association with the development of IBD; therefore, it was important to 
have these variables as covariates to account for any interactions. 
The statistical analysis test in this study included multinomial logistic regression 
analysis to evaluate the potential association between variables.  For example, exposure 
to cigarette smoke during childhood was the independent variable for both research 
questions; this variable was measured on a binary scale where individuals were coded as 
exposed or not exposed (i.e., not exposed = 1; exposed = 2).  Disease diagnosis was the 
dependent variable for RQ1; this variable was measured on a nominal scale where 
individuals were coded as having CD, UC, or non-IBD (i.e., non-IBD = 0; UC = 1; CD = 
2).  There were several covariates as well.  Sex was measured on a binary scale where 
individuals were coded as male or female (i.e., male = 0; female = 1).  Race was 
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measured on a binary scale where individuals were coded as White or Other (Black, more 
than one race, or other; i.e., White = 0; Other = 1); race had to be coded this way in order 
to include this variable in the analysis as it resulted in zeros in the crosstabulations when 
broken down further.  Relatives’ IBD status was measured on a binary scale where the 
relatives' disease status was coded as non-IBD or IBD (i.e., non-IBD = 0; IBD = 1).  
Breastfed as an infant was measured on a binary scale as being breastfed or not was 
coded (i.e., no = 1; yes = 2).  Daycare attendance was measured on a binary scale as 
attending daycare as a child or not was coded (i.e., no = 1; yes = 2).  Having pets growing 
up was measured on a binary scale as having a pet during childhood or not was coded 
(i.e., no = 1; yes = 2).  Born via C-section was measured on a binary scale as being born 
via C-section or not was coded (i.e., no = 1; yes = 2).  Born prematurely was measured on 
a binary scale as being born prematurely or not was coded (i.e., no = 1; yes = 2).  
Antibiotic treatment was measured on a binary scale as being treated with antibiotics 
before the age of 1 or not was coded (i.e., no = 1, yes = 2).  All of these covariates were 
included in RQ1 except born via C-section as a crosstabulation with the independent 
variable resulted in zeros in some categories. 
For RQ2, multinomial logistic regression was also conducted.  Childhood SHS 
exposure was the independent variable measured on a binary scale as in RQ1.  Age at 
diagnosis was the dependent variable measured on a nominal scale where individuals 
were coded into age groups based on the Montreal classification (i.e., 16 years or younger 
= 0; 17 to 40 years = 1; older than 40 years = 2).  The covariates for RQ2 were sex, 
relatives’ disease status, having pets growing up, born via C-section, and born 
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prematurely; the following variables were not included in RQ2 due to the 
crosstabulations resulting in zero individuals in some categories: race, breastfed as an 
infant, daycare attendance, and antibiotics before the age of 1.   
The results were interpreted based on the odds ratios and p values calculated by 
SPSS. 
Threats to Validity 
External Validity 
External validity involves the generalizability of the results of the study to the 
general population (San José State University, n.d.).  The four main types of threats to 
external validity are selection biases; constructs, methods, and confounding; the real 
world versus the experimental world; and history effects and maturation (Laerd 
Dissertation, 2012b).  In this study, selection bias could be a potential threat to external 
validity.  Selection bias occurs when the sample in the study is not representative of the 
population (Laerd Dissertation, 2012b; San José State University, n.d).  Selection bias 
can usually be prevented through random assignment of participants to groups (Laerd 
Dissertation, 2012b).  However, this was not possible with this secondary data analysis as 
the participants have already been placed into their designated groups (Laerd 
Dissertation, 2012b).  Selection bias was addressed by not limiting the sample to any one 
race or age to provide the best chance at having a representative sample (San José State 
University, n.d.).  However, there was not much that could be done to prevent selection 
bias since a convenience sample was used for this study. 
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Internal Validity 
Internal validity involves the conclusion from the research being an accurate 
portrayal of the association being studied (Laerd Dissertation, 2012c).  Internal validity is 
also concerned with anything other than the independent variable that might affect the 
dependent variable from within the study (Western Oregon University, n.d.).  The 14 
main types of internal validity threats are history effects, maturation, testing effects, 
instrumentation, statistical regression, selection biases, experimental mortality, causal 
time order, diffusion (or imitation) of treatments, compensation, compensation rivalry, 
demoralization, experimenter effects, and subject effects (Laerd Dissertation, 2012c). 
As with external validity, selection bias can also affect internal validity.  
However, as this study uses secondary data, the groups are already chosen; therefore, the 
random allocation of individuals was not possible.  Causal time order may also be a threat 
to internal validity for this study as it was assumed that childhood SHS exposure occurred 
before the development of IBD.  However, some of the data in the secondary data set 
were obtained by individuals who were diagnosed with IBD during childhood, so it is 
unclear if the SHS exposure occurred before, during, or after diagnosis.  Therefore, for 
these individuals, it was difficult to ascertain whether the independent variable (i.e., 
childhood SHS exposure) preceded the dependent variable (i.e., IBD diagnosis; Laerd 
Dissertation, 2012c). 
Construct Validity 
Construct validity deals with making sure the measurement procedure that is used 
to measure the construct is valid (Laerd Dissertation, 2012a).  The threats to construct 
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validity are inexact definitions of constructs, mono-operation bias, reducing levels of 
measurements of constructs, mono-method bias, treatment-sensitive factorial structure, 
and construct confounding (Laerd Dissertation, 2012a). 
A potential threat to construct validity for this study was inexact definitions of 
constructs.  This threat can be present if the definitions of constructs are too broad (not 
specific enough) or not completely thought out (Laerd Dissertation, 2012a).  This can be 
reduced by having a clear and concise operationalized definition for the constructs (Laerd 
Dissertation, 2012a).  By having a specific construct, the researcher can be more 
confident in the study and the results.  Mono-operation bias could also be present in this 
study as mono-operation results from only having one measure for a construct (Laerd 
Dissertation, 2012a).  In this study, childhood SHS exposure was measured as a nominal 
variable for exposed or not exposed to SHS as a child.  However, this variable/construct 
could indeed be broken down even further to include additional information, such as 
duration of SHS exposure and the source of the SHS exposure (i.e., cigarettes, cigars, 
vaporizers).  Reducing levels of measurements of constructs may also be a threat to 
construct validity in this study as the construct childhood SHS exposure could be 
measured more precisely if it was continuous (Laerd Dissertation, 2012a).  However, as 
this study uses secondary data, reducing these threats was not possible as the data set 
enforces limitations that could not be overcome. 
Ethical Procedures 
There were not any required agreements needed to gain access to the data since 
the data were publicly available.  Due to the nature of this secondary data set, there was 
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no human participation involved in my study, which negates the need for recruitment or 
data collection procedures.  The secondary data set that was used for this study consists 
of de-identified participant information.  There were no concerns regarding anonymity or 
confidentiality as the participants’ identifying information (i.e., name, address, phone 
number, birth date, etc.) were not included in the version of the data set that I was able to 
access.  For this study, I was the only one accessing this data; however, since it is made 
publicly available, anyone with Internet access can obtain the data.  No specific 
protections were necessary for the data as it were de-identified, anonymous, and 
confidential.  I had no conflicts of interest to report.  This study met Walden University’s 
ethical standards; the Institutional Review Board approval number for this study is 12-17-
19-0372015. 
Summary 
In Chapter 3, I examined the appropriate research design and methods that were 
used in this study.  Additionally, I highlighted the aspects of the data analysis plan, 
threats to validity, and ethical considerations for this study.  This detailed explanation of 
the methods of how this study was executed was used to determine the relationship 
between childhood SHS exposure and the development of IBD.  In Chapter 4, I will 
discuss the data collection and results of this study. 
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Chapter 4: Results  
Introduction 
The purpose of this study was to determine whether an association exists between 
childhood SHS exposure and IBD.  Smoking is known to be associated with IBD, but the 
relationship between childhood SHS exposure and IBD has not been thoroughly 
researched; therefore, any potential relationship is not understood.  In this study, I 
examined the relationship between childhood SHS exposure and IBD diagnosis as well as 
the relationship between childhood SHS exposure and the age of diagnosis for those 
diagnosed with IBD.  The research questions and hypotheses in this study were: 
RQ1: What is the association between childhood SHS exposure and the 
development of IBD after controlling for demographic (i.e., sex and race), 
genetic, and environmental factors? 
H01: There is no statistically significant association between childhood 
SHS exposure and the development of IBD after controlling for 
demographic, genetic, and environmental factors. 
Ha1: There is a statistically significant association between childhood SHS 
exposure and the development of IBD after controlling for demographic, 
genetic, and environmental factors. 
RQ2: What is the association between childhood SHS exposure and the age at 
diagnosis for those who have IBD after controlling for demographic (i.e., sex and 
race), genetic, and environmental factors? 
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H02: There is no statistically significant association between childhood 
SHS exposure and the age at diagnosis for those who have IBD after 
controlling for demographic, genetic, and environmental factors. 
Ha2: There is a statistically significant association between childhood SHS 
exposure and the age at diagnosis for those who have IBD after controlling 
for demographic, genetic, and environmental factors. 
In Chapter 4, I discuss the data collection process and the results of this study.  
G*Power 3.1.9.2 was used to calculate the sample size of this study using a power of 
80%, an alpha of 0.05, and an odds ratio of 2.48.  The statistical power of 80% and the 
alpha level of 0.05 were chosen because these are standard values for these parameters.  
The odds ratio of 2.48 was chosen because this is the value associated with a large effect 
size for logistic regression.  Based on these parameters, the desired sample size for this 
study was 71.  With the inclusion and exclusion criteria in mind, I was able to access data 
from a total of 74 individuals from the National Institutes of Health Integrative Human 
Microbiome Project: The IBDMDB.   
Data Collection 
As mentioned above, the data for this study were collected from the National 
Institutes of Health Integrative Human Microbiome Project: The IBDMDB; therefore, 
there was no time frame for data collection because all of the data were present upon 
accessing the data set.  I first accessed this data set for statistical analysis on December 
17, 2019 after receiving Institutional Review Board approval to proceed with my data 
collection and statistical analysis. 
47 
 
After evaluating the secondary data set, I assessed a total of 74 participants for 
this study.  The participants consisted of both children and adults of all ages and sexes 
with an IBD diagnosis of UC, CD, or non-IBD and a SHS exposure classification of yes 
or no.  Any individuals who did not have an IBD diagnosis response or a response 
regarding SHS exposure were excluded from the study.  Additionally, any individuals 
who were categorized as having UC or CD were excluded if an age at diagnosis was not 
also available.  A power analysis was conducted with an alpha level of 0.05, a sample 
size of 74, and an odds ratio of 2.48; this resulted in the true power of this study being 
0.82. 
The study consisted of data from 74 individuals of all ages and of different races 
and sexes.  I considered these factors as covariates in the analysis to control for any 
potential differences in these characteristics regarding diagnosis of IBD.  Generally 
speaking, IBD affects men and women equally; IBD is commonly diagnosed between the 
ages of 15 and 35 years old; and IBD affects Whites more than other races, but Blacks 
and Hispanics are more likely to experience extraintestinal complications than Whites 
(CCF, 2014; Moran, 2017).  Additional covariates were examined including genetic and 
environmental factors.   
Selection bias could have been present in this study because I conducted a 
secondary data analysis.  Selection bias occurs when the sample in the study is not 
representative of the population (Laerd Dissertation, 2012b; San José State University, 
n.d.).  While selection bias can usually be prevented through random assignment of 
participants into groups, this was not possible because the participants in the secondary 
48 
 
data were already placed into their designated groups (see Laerd Dissertation, 2012b).  
This threat to external validity was addressed by not limiting the sample to any one race, 
ethnicity, or age to provide the best chance at having a representative sample (see San 
José State University, n.d.).  In this study, little could be done to prevent selection bias 
since I used convenience sampling to collect the data from the secondary data set; 
however, since there were no limitations placed on these demographic variables, the 
sample might be more generalizable to the larger population. 
Results 
Descriptive Statistics  
Participant characteristics. Based on the aforementioned inclusion and 
exclusion criteria, all participants were children and adults of all ages with and without an 
IBD diagnosis who were or were not exposed to SHS during childhood.  I performed 
descriptive statistics for the continuous variable age at consent (not used in analysis).  For 
age of consent, the minimum was six years old, the maximum was 76 years old, the mean 
25.82 years old, the median was 16.00 years old, and the standard deviation was 18.227 
years old.   
Frequencies and percentages for age at consent.  Out of 74 participants ranging 
from ages of 6 to 76 years old, 16 years old was the most common age at consent with 
eight participants (10.8%) being this age.  The second most common age at consent was 
15 years old with seven participants (9.5%) being this age when consenting occurred.  
The frequency for age at consent is presented in Table 1. 
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Table 1 
Frequency for Age at Consent 
 Frequency Percent 
Valid 6 2 2.7 
7 1 1.4 
8 2 2.7 
9 2 2.7 
10 3 4.1 
11 4 5.4 
12 2 2.7 
13 4 5.4 
14 4 5.4 
15 7 9.5 
16 8 10.8 
17 3 4.1 
19 1 1.4 
21 1 1.4 
22 1 1.4 
23 1 1.4 
24 1 1.4 
26 2 2.7 
29 1 1.4 
30 2 2.7 
32 1 1.4 
37 2 2.7 
38 1 1.4 
40 1 1.4 
41 1 1.4 
43 1 1.4 
44 1 1.4 
45 1 1.4 
46 1 1.4 
50 1 1.4 
51 2 2.7 
55 1 1.4 
56 1 1.4 
57 1 1.4 
(table continues) 
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 Frequency Percent 
 60 1 1.4 
61 1 1.4 
62 2 2.7 
74 1 1.4 
76 1 1.4 
Total 74 100.0 
Frequencies and percentages for disease diagnosis. Out of 74 participants, 19 
participants (25.7%) were diagnosed with UC, 35 participants (47.3%) were diagnosed 
with CD, and 20 participants (27.0%) were not diagnosed with IBD.   
Frequencies and percentages for continuous age at diagnosis.  Out of 74 
participants, 54 participants (73.0%) were diagnosed with IBD with the age at diagnosis 
ranging from 5 to 74 years old.  The most common age at diagnosis was 16 years with 
seven participants (9.5%) being diagnosed with IBD at that age.  The 20 missing values 
represent the participants who were not diagnosed with IBD (i.e., non-IBD), so there is 
not an age at diagnosis for these participants.  The frequency for continuous age at 
diagnosis is presented in Table 2 
Table 2 
Frequency for Age at Diagnosis 
 Frequency Percent 
Valid 5 1 1.4 
6 1 1.4 
7 1 1.4 
8 2 2.7 
9 1 1.4 
10 2 2.7 
11 2 2.7 
(table continues) 
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 Frequency Percent 
 12 2 2.7 
13 4 5.4 
14 3 4.1 
15 6 8.1 
16 7 9.5 
17 1 1.4 
19 1 1.4 
21 1 1.4 
22 1 1.4 
24 2 2.7 
25 1 1.4 
26 1 1.4 
28 1 1.4 
29 2 2.7 
30 5 6.8 
37 1 1.4 
41 1 1.4 
43 1 1.4 
45 1 1.4 
58 1 1.4 
74 1 1.4 
Total 54 73.0 
Missing 999 20 27.0 
Total 74 100.0 
Frequencies and percentages for categorical age at diagnosis.  Out of the 54 
participants with an IBD diagnosis, the age at diagnosis ranged from 5 to 74 years old.  I 
grouped the age at diagnosis into categories based on the Montreal classification.  Thirty-
two participants (43.2%) were diagnosed at the age of 16 years old and younger, 17 
participants (23.0%) were diagnosed between 17 to 40 years old, and five participants 
(6.8%) were diagnosed at more than 40 years of age.   
Frequencies and percentages for childhood secondhand smoke exposure.  Out 
of 74 participants, 27 participants (36.5%) were exposed to SHS during childhood, while 
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47 participants (63.5%) were not exposed to SHS during childhood.   
Frequencies and percentages for sex.  Out of 74 participants, 38 participants 
(51.4%) were male and 36 participants (48.6%) were female.   
Frequencies and percentages for being breastfed as an infant.  Out of 74 
participants, 24 participants (32.4%) were not breastfed as an infant, 43 participants 
(58.1%) were breastfed as an infant, and seven participants (9.5%) were missing this 
data.   
Frequencies and percentages for taking antibiotics before the age of 1.  Out of 
74 participants, 16 participants (21.6%) did not take antibiotics before the age of 1, 22 
participants (29.7%) did take antibiotics before the age of 1, and 36 participants (48.6%) 
were missing this data.   
Frequencies and percentages for being born prematurely.  Out of 74 
participants, 59 participants (79.7%) were not born prematurely, nine participants 
(12.2%) were born prematurely, and six participants (8.1%) were missing this data.   
Frequencies and percentages for race.  Out of 74 participants, 67 participants 
(90.5%) were White, and seven (9.5%) were considered non-White (Black or African 
American, more than one race, other).  
Frequencies and percentages for relative’s disease diagnosis.  Out of 74 
participants, 53 participants (71.6%) did not have relatives with IBD, 19 participants 
(25.7%) did have relatives with IBD, and two participants (2.7%) were missing this data.   
Frequencies and percentages for having pets growing up.  Out of 74 
participants, 21 participants (28.4%) did not have pets growing up, 52 participants 
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(70.3%) did have pets growing up, and one participant (1.4%) was missing this data.   
Frequencies and percentages for daycare attendance as a child.  Out of 74 
participants, 43 participants (58.1%) did not attend daycare as a child, 30 participants 
(40.5%) did attend daycare as a child, and one participant (1.4%) was missing this data.   
Frequencies and percentages for born via C-section.  Out of 74 participants, 59 
participants (79.7%) were not born via C-section, 13 participants (17.6%) were born via 
C-section, and two participants (2.7%) were missing this data. 
Crosstabulations for Research Question 1 
A crosstabulation was performed for the dependent variable (i.e., disease 
diagnosis) and each independent variable.  Regarding the entire study population (n = 
74), it was determined that 47 participants were not exposed to SHS during childhood (12 
non-IBD, 12 with UC, 23 with CD) and 27 participants were exposed to SHS during 
childhood (eight non-IBD, seven with UC, 12 with CD).  The majority of the participants 
were not exposed to SHS during childhood.   
Regarding the entire study population (n = 74), it was determined that 38 
participants were male (10 non-IBD, eight with UC, 20 with CD) and 36 participants 
were female (10 non-IBD, 11 with UC, 15 with CD).  Overall, there was an equal 
distribution of males and females.   
Regarding the entire study population (n = 74), it was determined that 24 
participants were not breastfed as an infant (nine non-IBD, four with UC, 11 with CD), 
43 participants were breastfed as an infant (nine non-IBD, 14 with UC, 20 with CD), and 
seven participants were missing this data.  The majority of the participants were breastfed 
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as an infant.   
Regarding the entire study population (n = 74), it was determined that 16 
participants were not given antibiotics before the age of 1 (four non-IBD, eight with UC, 
four with CD), 22 participants were given antibiotics before the age of 1 (six non-IBD, 
two with UC, 14 with CD), and 36 participants were missing this data.  The majority of 
the participants were given antibiotics before the age of 1.   
Regarding the entire study population (n = 74), it was determined that 59 
participants were not born prematurely (14 non-IBD, 17 with UC, 28 with CD), nine 
participants were born prematurely (four non-IBD, one with UC, four with CD).  The 
majority of the participants were not born prematurely.   
Regarding the entire study population (n = 74), it was determined that 67 
participants were White (19 non-IBD, 16 with UC, 32 with CD) and seven participants 
were non-White (one non-IBD, three with UC, three with CD).  The majority of the 
participants were White.   
Regarding the entire study population (n = 74), it was determined that 53 
participants did not have relatives with an IBD diagnosis (16 non-IBD, 15 with UC, 22 
with CD), 19 participants did have relatives with an IBD diagnosis (four non-IBD, three 
with UC, 12 with CD), and two participants were missing this data.  The majority of the 
participants did not have a relative with an IBD diagnosis.   
Regarding the entire study population (n = 74), it was determined that 21 
participants did not have pets growing up (five non-IBD, three with UC, 13 with CD), 52 
participants did have pets growing up (15 non-IBD, 16 with UC, 21 with CD), and one 
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participant was missing this data.  The majority of the participants did have pets growing 
up.   
Regarding the entire study population (n = 74), it was determined that 43 
participants did not attend daycare as a child (15 non-IBD, 11 with UC, 17 with CD), 30 
participants did attend daycare as a child (five non-IBD, eight with UC, 17 with CD), and 
one participant was missing this data.  The majority of the participants did not attend 
daycare as a child.   
Childhood SHS Exposure and IBD Development 
A multinomial logistic regression analysis was conducted to examine the potential 
association between the independent variable (i.e., childhood SHS exposure) and the 
dependent variable (i.e., IBD diagnosis) while controlling for the potential effects of 
demographic (i.e., sex and race), genetic, and environmental variables.  The covariates 
for RQ1 were sex, race, relatives’ disease diagnosis, breastfed as an infant, daycare 
attendance, having pets growing up, born prematurely, and antibiotics before the age of 1; 
the following variable was not included in RQ1 due to the crosstabulations resulting in 
zero individuals in some categories: born via C-section. 
Table 3 contains the model fitting information which compares the overall model 
(i.e., including all predictors/independent variables) to the null model (i.e., does not 
include any predictors).  A p value of less than or equal to 0.05 is statistically significant 
which represents that the overall model is a better fit for the data when compared to the 
null model whereas a p value greater than 0.05 is nonsignificant which indicates that the 
final model is not a better fit for the data when compared to the null model.  The p value 
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of 0.666 is not significant at the 0.05 level, which means that the overall model is not a 
significant improvement in fit compared to the null model. 
Table 3 
Model Fitting Information 
Model 
Model Fitting 
Criteria Likelihood Ratio Tests 
-2 Log 
Likelihood Chi-Square Df Sig. 
Intercept only 64.972    
Final 50.026 14.946 18 .666 
Table 4 shows whether the model is a good fit for the data.  A p value of less than 
or equal to 0.05 is statistically significant which means that the model does not fit the 
data well, whereas a p value greater than 0.05 is nonsignificant which means that the 
model does fit the data well.  The Pearson chi-square value of 0.022 is statistically 
significant and indicates that the model does not fit the data well.  However, the deviance 
chi-square value of 0.144 is nonsignificant and indicates that the model does fit the data 
well.  Due to the conflicting results of the goodness of fit tests, it is difficult to determine 
if the model actually fits the data or not. 
Table 4 
Goodness-of-Fit 
 Chi-Square Df Sig. 
Pearson 57.485 38 .022 
Deviance 47.253 38 .144 
The Cox and Snell pseudo R-square value of 0.373 means that 37.3% of the 
variability in the dependent variable (i.e., disease diagnosis) can be explained (i.e., is 
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accounted for) by the independent variable (i.e., childhood SHS exposure).  The 
Nagelkerke pseudo R-square value of 0.424 means that 42.4% of the variability in the 
dependent variable (i.e., disease diagnosis) can be explained (i.e., is accounted for) by the 
independent variable (i.e., childhood SHS exposure).  The McFadden pseudo R-square 
value of 0.221 means that 22.1% of the variability in the dependent variable (i.e., disease 
diagnosis) can be explained (i.e., is accounted for) by the independent variable (i.e., 
childhood SHS exposure).   
In Table 5, the likelihood ratio tests test the contribution of each independent 
variable to the overall model.  The variable antibiotics before the age of 1 is the only 
statistically significant independent variable for this model with a p value of 0.048.  All 
other independent variables are nonsignificant at the 0.05 significance level. 
Table 5 
Likelihood Ratio Tests 
Effect 
Model Fitting 
Criteria Likelihood Ratio Tests 
-2 Log 
Likelihood of 
Reduced 
Model Chi-Square Df Sig. 
Intercept 50.026a .000 0 . 
Childhood SHS exposure 51.373 1.348 2 .510 
Sex 50.551 .525 2 .769 
Breastfed as infant 50.213 .187 2 .911 
Antibiotics before age 1 56.090 6.064 2 .048 
Born prematurely 52.127 2.101 2 .350 
Race 50.031 .006 2 .997 
Relatives’ disease 
diagnosis 
50.327 .301 2 .860 
(table continues) 
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Model Fitting 
Criteria Likelihood Ratio Tests 
-2 Log 
Likelihood of 
Reduced 
Model Chi-Square Df Sig. 
Have pets growing up 51.333 1.308 2 .520 
     
Daycare attendance 50.368 .342 2 .843 
Note. The chi-square statistic is the difference in -2 log-likelihoods 
between the final model and a reduced model. The reduced model is 
formed by omitting an effect from the final model. The null hypothesis 
is that all parameters of that effect are 0. 
a. This reduced model is equivalent to the final model because omitting 
the effect does not increase the degrees of freedom. 
Table 6 compared each of the UC and CD diagnoses to the reference group (i.e., 
non-IBD) for each independent variable.  None of the independent variables were 
statistically significant for the comparison between UC and non-IBD; likewise, none of 
the independent variables were statistically significant for the comparison between CD 
and non-IBD. 
Table 6 
Parameter Estimates 
Disease Diagnosisa B 
Std. 
Error Wald df Sig. Exp(B) 
95% Confidence 
Interval for 
Exp(B) 
Lower 
Bound 
Upper 
Bound 
Ulcerative 
colitis 
Intercept -2.066 5.831 .125 1 .723    
Daycare 
attendance 
.590 1.448 .166 1 .684 1.804 .106 30.788 
Childhood SHS 
exposure 
.269 1.712 .025 1 .875 1.309 .046 37.483 
(table continues) 
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Disease Diagnosisa B 
Std. 
Error Wald df Sig. Exp(B) 
95% Confidence 
Interval for 
Exp(B) 
Lower 
Bound 
Upper 
Bound 
 Born 
prematurely 
-1.605 1.555 1.066 1 .302 .201 .010 4.229 
Breastfed as 
infant 
.719 1.702 .178 1 .673 2.052 .073 57.632 
Antibiotics 
before age 1 
-.971 1.262 .592 1 .442 .379 .032 4.492 
Relatives' 
disease 
diagnosis 
-.205 1.690 .015 1 .903 .815 .030 22.346 
Race .145 2.216 .004 1 .948 1.157 .015 89.041 
Sex .974 1.432 .463 1 .496 2.649 .160 43.852 
Have pets 
growing up 
1.367 1.620 .712 1 .399 3.923 .164 93.913 
Crohn's 
disease 
Intercept -1.817 4.781 .144 1 .704    
Daycare 
attendance 
-.143 1.201 .014 1 .906 .867 .082 9.127 
Childhood SHS 
exposure 
1.501 1.525 .969 1 .325 4.487 .226 89.153 
Born 
prematurely 
-1.790 1.478 1.467 1 .226 .167 .009 3.023 
Breastfed as 
infant 
.332 1.206 .076 1 .783 1.394 .131 14.828 
Antibiotics 
before age 1 
1.653 1.149 2.069 1 .150 5.224 .549 49.709 
Relatives' 
disease 
diagnosis 
.499 1.254 .158 1 .691 1.646 .141 19.236 
Race .122 2.006 .004 1 .951 1.130 .022 57.569 
Sex .214 1.180 .033 1 .856 1.238 .123 12.510 
Have pets 
growing up 
-.286 1.308 .048 1 .827 .751 .058 9.756 
a. The reference category is: non-IBD. 
Table 7 shows the predictive ability of the model for each diagnosis group.  The 
diagnosis of non-IBD was predicted by the model 37.5% of the time.  The diagnosis of 
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UC was predicted by the model 66.7% of the time.  The diagnosis of CD was predicted 
73.3% of the time.  The overall predictive ability was 62.5%. 
Table 7 
Classification 
Observed 
Predicted 
non-IBD 
ulcerative 
colitis 
Crohn's 
disease 
Percent 
Correct 
non-IBD 3 2 3 37.5% 
Ulcerative colitis 1 6 2 66.7% 
Crohn's disease 2 2 11 73.3% 
Overall percentage 18.8% 31.3% 50.0% 62.5% 
Crosstabulations for Research Question 2 
A crosstabulation was performed for the dependent variable (i.e., age at diagnosis) 
and each independent variable.  Regarding the participants who were diagnosed with IBD 
(n = 54), it was determined that at the time of diagnosis 32 participants were aged 16 
years or younger (10 with UC, 22 with CD), 17 participants were diagnosed between the 
ages of 17 and 40 years (seven with UC, 10 with CD), and five participants were 
diagnosed at more than 40 years of age (two with UC, three with CD).  The majority of 
the participants were diagnosed at 16 years of age or younger.   
Regarding the participants who were diagnosed with IBD (n = 54), it was 
determined that 35 participants were not exposed to SHS exposure during childhood (21 
aged 16 years and younger, 11 aged 17 to 40 years, and three aged more than 40 years) 
and 19 participants were exposed to SHS exposure during childhood (11 aged 16 years 
and younger, six aged 17 to 40 years, and two aged more than 40 years).  The majority of 
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the participants were not exposed to SHS exposure during childhood. 
Regarding the participants who were diagnosed with IBD (n = 54), it was 
determined that 45 participants were not born prematurely (29 aged 16 years and 
younger, 12 aged 17 to 40 years, and four aged more than 40 years), five participants 
were born prematurely (one aged 16 years and younger, three aged 17 to 40 years, and 
one aged more than 40 years), and four participants were missing this data.  The majority 
of the participants were not born prematurely.   
Regarding the participants who were diagnosed with IBD (n = 54), it was 
determined that 43 participants were not born via C-section (25 aged 16 years and 
younger, 14 aged 17 to 40 years, and four aged more than 40 years), nine participants 
were born via C-section (five aged 16 years and younger, three aged 17 to 40 years, and 
one aged more than 40 years), and two participants were missing this data.  The majority 
of the participants were not born via C-section.   
Regarding the participants who were diagnosed with IBD (n = 54), it was 
determined that 16 participants did not have pets growing up (11 aged 16 years and 
younger, four aged 17 to 40 years, and one aged more than 40 years), 37 participants did 
have pets growing up (21 aged 16 years and younger, 13 aged 17 to 40 years, and three 
aged more than 40 years), and one participant was missing this data.  The majority of the 
participants did have pets growing up.   
Regarding the participants who were diagnosed with IBD (n = 54), it was 
determined that 37 participants did not have relatives with IBD (22 aged 16 years and 
younger, 11 aged 17 to 40 years, and four aged more than 40 years), 15 participants did 
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have relatives with IBD (nine aged 16 years and younger, five aged 17 to 40 years, and 
one aged more than 40 years), and two participants who were missing this data.  The 
majority of the participants did not have relatives with IBD.   
Regarding the participants who were diagnosed with IBD (n = 54), it was 
determined that 28 participants were male (20 aged 16 years and younger, five aged 17 to 
40 years, and three aged more than 40 years) and 26 participants were female (12 aged 16 
years and younger, 12 aged 17 to 40 years, and two aged more than 40 years). About half 
of the participants were male and about half of the participants were female.   
Childhood SHS Exposure and Age at Diagnosis for Individuals Diagnosed with IBD   
A multinomial logistic regression analysis was conducted to examine the potential 
association between the independent variable (i.e., childhood SHS exposure) and the 
dependent variable (i.e., age at diagnosis) for those individuals diagnosed with IBD 
development while controlling for the potential effects of demographic (i.e., sex and 
race), genetic, and environmental variables.  The covariates for RQ2 were sex, relatives’ 
disease status, having pets growing up, born via C-section, and born prematurely; the 
following variables were not included in RQ2 due to the crosstabulations resulting in zero 
individuals in some categories: race, breastfed as an infant, daycare attendance, and 
antibiotics before the age of 1. 
Table 8 contains the model fitting information which compares the overall model 
(i.e., including all predictors/independent variables) to the null model (i.e., does not 
include any predictors).  A p value of less than or equal to 0.05 is statistically significant 
which represents that the overall model is a better fit for the data when compared to the 
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null model whereas a p value greater than 0.05 is nonsignificant which indicates that the 
final model is not a better fit for the data when compared to the null model.  The p value 
of 0.560 is not significant at the 0.05 level, which means that the overall model is not a 
significant improvement in fit compared to the null model. 
Table 8 
Model Fitting Information 
Model 
Model Fitting 
Criteria Likelihood Ratio Tests 
-2 Log 
Likelihood Chi-Square Df Sig. 
Intercept only 60.476    
Final 49.834 10.642 12 .560 
Table 9 shows whether the model is a good fit for the data.  A p value of less than 
or equal to 0.05 is statistically significant which means that the model does not fit the 
data well, whereas a p value greater than 0.05 is nonsignificant which means that the 
model does fit the data well.  The Pearson chi-square value of 0.110 is nonsignificant and 
indicates that the model fits the data well.  The deviance chi-square value of 0.158 is also 
nonsignificant and indicates that the model fits the data well.   
Table 9 
Goodness-of-Fit 
 Chi-Square Df Sig. 
Pearson 39.733 30 .110 
Deviance 37.678 30 .158 
The Cox and Snell pseudo R-square value of 0.207 means that 20.7% of the 
variability in the dependent variable (i.e., age at diagnosis) can be explained by the 
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independent variable (i.e., childhood SHS exposure).  The Nagelkerke pseudo R-square 
value of 0.250 means that 25.0% of the variability in the dependent variable (i.e., age at 
diagnosis) can be explained by the independent variable (i.e., childhood SHS exposure).  
The McFadden pseudo R-square value of 0.132 means that 13.2% of the variability in the 
dependent variable (i.e., age at diagnosis) can be explained by the independent variable 
(i.e., childhood SHS exposure).   
In Table 10, the likelihood ratio tests test the contribution of each independent 
variable to the overall model.  None of the independent variables are significant at the 
0.05 significance level. 
Table 10 
Likelihood Ratio Tests 
Effect 
Model Fitting 
Criteria Likelihood Ratio Tests 
-2 Log 
Likelihood of 
Reduced 
Model Chi-Square Df Sig. 
Intercept 49.834a .000 0 . 
Childhood SHS exposure 50.381 .547 2 .761 
Born prematurely 52.553 2.719 2 .257 
Born via C-section 50.322 .488 2 .783 
Have pets growing up 51.475 1.641 2 .440 
Relatives' disease 
diagnosis 
49.959 .125 2 .939 
Sex 54.033 4.199 2 .122 
Note. The chi-square statistic is the difference in -2 log-likelihoods 
between the final model and a reduced model. The reduced model is 
formed by omitting an effect from the final model. The null hypothesis 
is that all parameters of that effect are 0. 
a. This reduced model is equivalent to the final model because omitting 
the effect does not increase the degrees of freedom. 
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Table 11 compared each of the age at diagnosis groups (i.e., 17 to 40 years old 
and more than 40 years old) to the reference group (i.e., 16 years old and younger) for 
each independent variable.  None of the independent variables were statistically 
significant for the comparison between the 17 to 40 years old group and the 16 years old 
and younger group;  likewise, none of the independent variables were statistically 
significant for the comparison between the over 40 years old group and the 16 years old 
and younger group. 
Table 11 
Parameter Estimates 
Age at Diagnosis 
(categorical)a B 
Std. 
Error Wald df Sig. Exp(B) 
95% Confidence 
Interval for Exp(B) 
Lower 
Bound 
Upper 
Bound 
17 to 40 
years 
Intercept -5.333 2.788 3.658 1 .056    
Childhood SHS 
exposure 
.286 .784 .133 1 .715 1.332 .286 6.195 
Born prematurely 1.810 1.323 1.870 1 .171 6.108 .457 81.695 
Born via C-
section 
-.632 1.115 .322 1 .571 .531 .060 4.725 
Have pets 
growing up 
1.148 .951 1.458 1 .227 3.152 .489 20.322 
Relatives’ disease 
diagnosis 
.319 .930 .118 1 .732 1.376 .222 8.510 
Sex 1.591 .821 3.755 1 .053 4.911 .982 24.559 
more than 
40 years 
Intercept -6.452 3.749 2.962 1 .085    
Childhood SHS 
exposure 
.846 1.190 .506 1 .477 2.331 .226 24.016 
Born prematurely 2.089 1.689 1.530 1 .216 8.077 .295 221.224 
Born via C-
section 
.286 1.524 .035 1 .851 1.331 .067 26.364 
(table continues) 
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 B 
Std. 
Error Wald df Sig. Exp(B) 
95% Confidence 
Interval for Exp(B) 
Lower 
Bound 
Upper 
Bound 
 Have pets 
growing up 
.286 1.299 .049 1 .826 1.331 .104 16.982 
Relatives' disease 
diagnosis 
.208 1.396 .022 1 .882 1.231 .080 19.007 
Sex .243 1.272 .036 1 .849 1.275 .105 15.424 
a. The reference category is: 16 years and younger. 
Table 12 shows the predictive ability of the model for each diagnosis group.  The 
age at diagnosis of 16 years and younger was predicted by the model 82.1% of the time.  
The age at diagnosis of 17 to 40 years was predicted by the model 64.3% of the time.  
The age at diagnosis of more than 40 years was predicted by the model 0.0% of the time.  
The overall predictive ability was 69.6%. 
Table 12 
Classification 
Observed 
Predicted 
16 years and 
younger 17 to 40 years 
more than 40 
years 
Percent 
Correct 
16 years and younger 23 5 0 82.1% 
17 to 40 years 5 9 0 64.3% 
more than 40 years 2 2 0 0.0% 
Overall percentage 65.2% 34.8% 0.0% 69.6% 
Summary 
 The purpose of this study was to examine the potential relationship between 
childhood SHS exposure and IBD diagnosis while controlling for demographic, genetic, 
and environmental covariates.  Additionally, this study also investigated the potential 
relationship between childhood SHS exposure and age at diagnosis for individuals 
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diagnosed with IBD while controlling for demographic, genetic, and environmental 
covariates.  Regarding RQ1, there was not a statistically significant association between 
childhood SHS exposure and the development of IBD after controlling for demographic, 
genetic, and environmental factors; I failed to reject the null hypothesis for RQ1.  
Regarding RQ2, there was not a statistically significant association between childhood 
SHS exposure and the age at diagnosis for those who have IBD after controlling for 
demographic, genetic, and environmental factors; I failed to reject the null hypothesis for 
RQ2. 
The findings of this study will be considered further in Chapter 5 by comparing 
the findings of this study to existing literature results.  In Chapter 5, I will also discuss the 
limitations of this study, recommendations for future research relative to this specific 
topic, and implications of these results.    
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this study was to examine the association between childhood SHS 
exposure and the development of IBD after controlling for demographic (i.e., sex and 
race), genetic, and environmental covariates.  In addition, I also examined the association 
between childhood SHS exposure and the age of IBD diagnosis after controlling for 
covariates.  The covariates used were sex, race, relatives’ disease diagnosis, breastfed as 
an infant, daycare attendance, having pets growing up, born via C-section, born 
prematurely, and antibiotics before the age of 1.   
Previous literature has shown that studies regarding the effect of smoking and 
IBD have been conducted; however, research regarding SHS exposure and IBD is 
limited.  Examining the association between SHS exposure during childhood could 
contribute to the knowledge regarding the effects of environmental factors on the 
development of IBD.  The findings of this study could lead to physicians learning more 
about the causes of these diseases and individuals having a better understanding of their 
potential risks associated with the environment. 
In this study, I used a quantitative approach and a cross-sectional design to assess 
the association between the independent and dependent variables.  Secondary data from 
the National Institutes of Health were used for this study because the data set contained 
information regarding individuals with and without IBD who were or were not exposed 
to SHS exposure during childhood.  Multinomial logistic regression was performed for 
both research questions to determine if there was an association between the independent 
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and dependent variables while controlling for demographic, genetic, and environmental 
covariates. 
The findings of this study were not statistically significant for both research 
questions.  For RQ1, the overall model was not significant; however, the variable of 
antibiotics before the age of 1 was found to be statistically significant when only 
comparing its specific contribution to the overall model.  For RQ2, none of the findings 
were significant.   
Interpretation of the Findings 
The overall scope of the study was to examine the relationship between childhood 
SHS exposure and IBD diagnosis.  The sample population of this study consisted of 74 
children and adults of all ages with and without an IBD diagnosis who were or were not 
exposed to SHS during childhood.  The first research question was: What is the 
association between childhood SHS exposure and the development of IBD after 
controlling for demographic (i.e., sex and race), genetic, and environmental factors?  The 
second research question was: What is the association between childhood SHS exposure 
and the age at diagnosis for those who have IBD after controlling for demographic (i.e., 
sex and race), genetic, and environmental factors?  Previous researchers had not fully 
examined the potential association between childhood SHS exposure and the 
development of IBD; therefore, there was limited literature that directly related to either 
research question.  Since the results of the multinomial logistic regression tests for both 
research questions were not statistically significant, the findings of this study did not 
confirm, disconfirm, or extend any previous knowledge regarding the main variables in 
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both research questions; however, previous literature regarding the covariates were used 
in this study. 
The covariates used in this study were sex, race, relatives’ disease diagnosis, 
breastfed as an infant, daycare attendance, having pets growing up, born via C-section, 
born prematurely, and use of antibiotics before the age of 1.  Use of antibiotics before the 
age of 1 was the only independent variable that was statistically significant (p value = 
0.048) in contributing to the overall model (see Table 5).  This variable was significant in 
contributing to the overall model; however, this variable was not statistically significant 
when the groups of disease diagnosis were compared (see Table 6).  Previous researchers 
stated that the use of antibiotics has been associated with new cases of CD but not UC 
(Ungaro et al., 2014).  Future research is needed to further understand the potential 
association between antibiotics and IBD development.  The other covariates were also 
mentioned briefly in previous literature, but the nonsignificant results of these variables 
do not contribute any meaning to the literature or fill any gaps in the literature.  Further 
research is also needed to evaluate these variables to determine whether they are involved 
in the development of IBD because there is currently only a limited amount of research 
available regarding early life exposures and the development of IBD. 
As stated previously, the only variable that was statistically significant (p value = 
0.048) for this study was use of antibiotics before the age of 1 when examining the 
contribution of each independent variable to the overall model (see Table 5). Therefore, I 
can only interpret the theoretical framework in terms of use of antibiotics before the age 
of 1.  The theoretical framework I used in this study was Bronfenbrenner’s ecological 
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systems theory, which is based on the premise that there are multiple systems in which an 
individual lives and that each system contributes to the development of an individual 
(The Psychology Notes Headquarter, 2013).  In this interpretation, the use of antibiotics 
before age 1 can be considered to be a part of the microsystem of the individual because 
it directly affects the individual; the potential for the use of antibiotics before the age of 1 
to have an effect on the development of the individual over time is considered part of the 
chronosystem.  In this context, there is an association between the use of antibiotics 
before the age of 1 and the IBD diagnosis over time since the use of antibiotics before the 
age of 1 is statistically significant in contributing to the overall model.  However, since 
the use of antibiotics before the age of 1 was not statistically significant when the 
different groups of IBD diagnosis were compared, it is not possible to say exactly what 
kind of association exists between the use of antibiotics before the age of 1 and IBD 
diagnosis.  More research is needed in the future to further explore this relationship.  
Additionally, more research is also needed to further explore the potential for an 
association between IBD diagnosis and other environmental factors. 
Limitations of the Study 
I identified several limitations in this study.  The first limitation was the use of a 
secondary data set to perform the analyses needed to answer the research questions.  This 
is considered a limitation for a couple of reasons.  First, the secondary data set was not 
originally collected for the purposes of this study, so the data were not intended to answer 
the research questions posed in this study (see Cheng & Phillips, 2014).  Second, because 
I was not involved with the data collection process, there might be additional aspects of 
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the data that I could not account for regarding the variables (see Cheng & Phillips, 2014).  
For example, the variable childhood SHS exposure was my main independent variable; 
however, the variable is vague, and I cannot know if the participants who were diagnosed 
as children were exposed to SHS before, during, or after being diagnosed; this could lead 
to some complications if I was trying to determine causation rather than correlation. 
Another limitation of this study was the small sample size, which could have 
affected the results of the study in several ways.  A small sample size decreases the 
generalizability of the extrapolation of the findings; this is the same as saying that the 
sample is not representative of the population (Faber & Fonseca, 2014).  Studies with 
small samples may not yield reliable or precise results (Hackshaw, 2008).  Since I was 
using a secondary data set to collect data for my study, I was unable to control the sample 
size.  I had to use what was available in the secondary data set.  The data set contained 
several entries for the same patient, which led to eliminating entries of duplicates.  In 
addition, the inclusion and exclusion factors had to be met for a participant to be included 
in this research study; these factors greatly limited the number of participants that could 
be included.  There were also limitations regarding the included covariates and the 
potential covariates that were excluded.  Race was included in the analyses, but instead of 
using the predetermined groups (i.e., White, Black or African American, more than one 
race, and other), the last three groups had to be combined, which resulted in only two 
groups (i.e., White and Other).  This recategorization was essential in order to be able to 
include race at all since there were not enough participants in the remaining groups.  
Ethnicity was not able to be included in the analyses due to a limited response of those 
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who were Hispanic or Latino.  Relatives’ disease diagnosis also had to be modified to be 
able to include it in the analysis; instead of having several groups that distinctly explained 
all of the possibilities, this variable had to be grouped into the participant having relatives 
with IBD or the participant having relatives without IBD.  There was no specification of 
IBD allowed in order to include this variable of relatives’ disease diagnosis in the 
analyses.  However, since genetics plays a role in the development of IBD, this was a 
very important variable to include (CCF, 2014; Orholm et al., 1991).  The change in the 
categorization of and the exclusion of these aforementioned variables from the analysis 
resulted in the sample not being representative of the entire population.  A larger sample 
size could have potentially increased the number of usable covariates and decreased the 
amount of regrouping of some variables. 
Recommendations 
After conducting and reviewing the results of this study, I have some 
recommendations for further study.  First, I recommend that research regarding IBD and 
children is continually performed; the ethical issues that are evident when involving 
vulnerable populations, such as children, in research can keep relevant and crucial 
research from being conducted, but vulnerable populations need the most help in terms of 
research results.  In the literature, there has not been enough research performed that 
involves children with IBD and environmental or other factors that can help determine 
the causes of these diseases.   
I also recommend that this research study be repeated with different samples.  The 
sample size (n = 74) was very small and did not allow for a proper comparison between 
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the different groups of IBD diagnosis.  A more diverse sample would also be beneficial 
because it is important to study the differences in diseases for different races and 
ethnicities in order to be able to tailor treatments or preventive measures to those 
individuals who might be more susceptible to developing IBD.  In addition, since the 
amount of data on IBD and environmental exposures was very limited, it might be 
beneficial to conduct a primary data analysis; although this would definitely be more time 
consuming, the researcher would be able to play a role in the data collection process and 
gain insight into any idiosyncrasies seen in the data.  Repeating this study with different 
samples would also be important; even if the results were statistically significant for this 
study, the results can only be generalized so far, and research can only be proved with 
repetition.  One study is not enough to determine clarity on the relationships between 
variables. 
Implications 
Social Change 
This study, along with future related research, has the potential to have an impact 
for positive social change at many levels.  This study could lead to additional studies that 
might examine the risk of an individual for developing IBD.  Knowledge of personal 
risks of disease could lead to preventative measures that might eliminate or reduce the 
chance of an individual developing the disease.  This research, and others like it, might 
help those diagnosed with IBD because they will see that they are not alone in this fight 
against the disease.  Since these diseases tend to run in families, it is important to 
examine the potential risk factors for individuals within the family as well.  If an 
75 
 
environmental factor, such as SHS, is determined to be associated with the development 
of IBD, then it would be important to examine the habits (in this case, smoking) of family 
members that might increase the risk for IBD for the entire family.  In addition to the 
individual and family levels, it is important to consider the community level, which can 
focus on taking these results and transforming them into policies that may help prevent 
the development of IBD and focus on increasing public health and awareness regarding 
GI diseases.  Furthermore, physicians can use research regarding potential risk factors to 
help them better diagnose and prepare individuals for the treatment of IBD.  
Theoretical Framework 
As previously mentioned, the theoretical framework for this study was 
Bronfenbrenner’s ecological systems theory, which has been used previously in social 
work, education, psychology, policymaking, and public health (“Ecological systems 
theory,” 2018).  This theory suggests that the environment of an individual affects the 
individual’s growth and development and that there are many different levels of an 
individual’s environment that all interact together (“Ecological systems theory,” 2018).  
Bronfenbrenner’s ecological systems theory was used as the framework for this study 
while keeping in mind the effects that the environment, at many different levels, might 
influence the health of an individual.  I only examined the microsystem and the 
chronosystem in this study because the microsystem consists of the individual’s direct 
environment (i.e., represented by SHS exposure), and the chronosystem represents the 
development over time (i.e., represented by the development of IBD; see “Ecological 
systems theory,” 2018).  I evaluated the potential association between childhood SHS 
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exposure and IBD development with this theory as the underlying basis for how the 
environment can play a role in the development of an individual. 
Recommendations for Practice 
The results from this study were aimed at determining an additional risk factor for 
IBD development that might aid in guiding physicians regarding the prevention and 
diagnosis of IBD.  The findings indicated the need for additional studies in order to 
increase knowledge regarding IBD and the potential associations between environmental 
exposures and IBD development.  The nonsignificance of these results also showed that 
more work is needed to create a valuable research design.  The lack of ability to gather a 
meaningful sample size should lead professionals to try to find new ways to reach out to 
patients and extend the pool of patients for analysis in order to be able to obtain relevant 
and significant data.  The statistically significant result for the use of antibiotics before 
the age of 1 occurred only when comparing the effects of each variable to the overall 
model.  Conducting studies with a larger sample size can lead to better results because 
more variables can also be evaluated without worrying about some groups having zero 
frequencies, which was the major problem with this study. 
Conclusion 
Although there are several studies regarding IBD development, the exact causes 
of IBD are unknown.  Researchers believe the cause of IBD to be multifactorial and 
include genetics, environmental factors, and the immune system response (CCF, 2014; 
Moran, 2017).  There is also a very limited amount of extant studies regarding children 
and IBD.  This is most likely due to ethical concerns regarding the use of children in 
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research because they are vulnerable populations.  While additional protections are 
necessary for children in research, it is extremely important for research to be conducted 
with this population in mind because their bodies are different than adults so it is 
difficult, and slightly impractical, to generalize the results from adult studies to the IBD 
population of children.   
There are studies in the current literature that focus on the effect of smoking on 
the development of IBD; however, studies regarding childhood SHS exposure are not 
available.  Therefore, in this study, I examined the potential association between 
childhood SHS exposure and the development of IBD as well as the potential association 
between childhood SHS exposure and the age of diagnosis for those individuals 
diagnosed with IBD.  The results of this study were nonsignificant except for when it 
comes to the variable of the use of antibiotics before the age of 1, but this variable was 
only statistically significant when determining its effect on the overall model. 
With this study, I sought to address the gap in the literature; however, a small 
sample size, the major limitation, did not allow the results to address this gap.  Future 
research, hopefully with a much larger sample size, could now address this gap while 
steering clear of the limitations and pitfalls of this study.  Even though this research 
provided very limited results, it is still important because future researchers can adapt to 
the complications seen in this study and use the limitations of this study to conduct 
research that might lead to statistically significant results. 
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